biosample_id	individual_id	callset_ids	pgx_legacy_sample_id	legacy_ids	description	histological_diagnosis_id	histological_diagnosis_label	icdo_morphology_id	icdo_morphology_label	icdo_topography_id	icdo_topography_label	sampled_tissue_id	tnm	stage	grade	age_iso	death	followup_state_id	followup_state_label	followup_time	recurrence	recurrence_time	geoprov_city	geoprov_country	geoprov_iso_alpha3	geoprov_lat	geoprov_long	cnv_fraction	cnv_del_fraction	cnv_dup_fraction	cell_line	experiment_id	series_id	platform_id	cell_line_id	cell_line_label	external_references__id___PMID	external_references__label___PMID	external_references__id___geo:GSM	external_references__label___geo:GSM	external_references__id___geo:GSE	external_references__label___geo:GSE	external_references__id___geo:GPL	external_references__label___geo:GPL	external_references__id___cellosaurus	external_references__label___cellosaurus	external_references__id___arrayexpress	external_references__label___arrayexpress	external_references__id___cbioportal	external_references__label___cbioportal	followup_state__id	followup_state__label	data_use_conditions__id	data_use_conditions__label
pgxbs-kftva6e2	pgxind-kftx26nq	pgxcs-kftvlmx8		PGX_AM_BS_AdSqLu-bjo-22	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgio6	pgxind-kftx28pl	pgxcs-kftvm52o		PGX_AM_BS_24174329-clc-S00020	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgipb	pgxind-kftx28qy	pgxcs-kftvm5eb		PGX_AM_BS_24174329-clc-S00022	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgipk	pgxind-kftx28r7	pgxcs-kftvm5gn		PGX_AM_BS_24174329-clc-S00027	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgipq	pgxind-kftx28rf	pgxcs-kftvm5ii		PGX_AM_BS_24174329-clc-S00031	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiq3	pgxind-kftx28rv	pgxcs-kftvm5o8		PGX_AM_BS_24174329-clc-S00045	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgir1	pgxind-kftx28sz	pgxcs-kftvm5xn		PGX_AM_BS_24174329-clc-S00066	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgir9	pgxind-kftx28t8	pgxcs-kftvm5zy		PGX_AM_BS_24174329-clc-S00072	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgis6	pgxind-kftx28uc	pgxcs-kftvm69a		PGX_AM_BS_24174329-clc-S00093	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgisf	pgxind-kftx28un	pgxcs-kftvm6bm		PGX_AM_BS_24174329-clc-S00099	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgisi	pgxind-kftx28ur	pgxcs-kftvm6cj		PGX_AM_BS_24174329-clc-S00101	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgitz	pgxind-kftx28wl	pgxcs-kftvm6rw		PGX_AM_BS_24174329-clc-S00141	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiu1	pgxind-kftx28wn	pgxcs-kftvm6ud		PGX_AM_BS_24174329-clc-S00142	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiuf	pgxind-kftx28x3	pgxcs-kftvm6y9		PGX_AM_BS_24174329-clc-S00176	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiul	pgxind-kftx28xa	pgxcs-kftvm705		PGX_AM_BS_24174329-clc-S00157	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiuv	pgxind-kftx28xm	pgxcs-kftvm72z		PGX_AM_BS_24174329-clc-S00163	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgivh	pgxind-kftx28ye	pgxcs-kftvm79k		PGX_AM_BS_24174329-clc-S00177	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgivp	pgxind-kftx28yo	pgxcs-kftvm7bx		PGX_AM_BS_24174329-clc-S00182	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgivt	pgxind-kftx28ys	pgxcs-kftvm7cv		PGX_AM_BS_24174329-clc-S00184	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgiw1	pgxind-kftx28z1	pgxcs-kftvm7f8		PGX_AM_BS_24174329-clc-S00189	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiwh	pgxind-kftx28zl	pgxcs-kftvm7jx		PGX_AM_BS_24174329-clc-S00199	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgix2	pgxind-kftx290b	pgxcs-kftvm7q2		PGX_AM_BS_24174329-clc-S00213	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgixh	pgxind-kftx290t	pgxcs-kftvm7ub		PGX_AM_BS_24174329-clc-S00228	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgixi	pgxind-kftx290u	pgxcs-kftvm7us		PGX_AM_BS_24174329-clc-S00230	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgixv	pgxind-kftx291a	pgxcs-kftvm7yj		PGX_AM_BS_24174329-clc-S00238	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgizh	pgxind-kftx2938	pgxcs-kftvm8hj		PGX_AM_BS_24174329-clc-S00283	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj04	pgxind-kftx2940	pgxcs-kftvm8od		PGX_AM_BS_24174329-clc-S00312	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj09	pgxind-kftx2946	pgxcs-kftvm8ps		PGX_AM_BS_24174329-clc-S00316	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj13	pgxind-kftx2955	pgxcs-kftvm8yc		PGX_AM_BS_24174329-clc-S00342	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1e	pgxind-kftx295k	pgxcs-kftvm91n		PGX_AM_BS_24174329-clc-S00396	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1j	pgxind-kftx295q	pgxcs-kftvm932		PGX_AM_BS_24174329-clc-S00354	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1x	pgxind-kftx2968	pgxcs-kftvm99d		PGX_AM_BS_24174329-clc-S00364	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj2c	pgxind-kftx296q	pgxcs-kftvm9dr		PGX_AM_BS_24174329-clc-S00393	adenosquamous carcinoma [lung]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj3d	pgxind-kftx297z	pgxcs-kftvm9oi		PGX_AM_BS_24174329-clc-S00417	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj3r	pgxind-kftx298g	pgxcs-kftvm9s9		PGX_AM_BS_24174329-clc-S00426	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj45	pgxind-kftx298y	pgxcs-kftvm9wf		PGX_AM_BS_24174329-clc-S00436	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj5q	pgxind-kftx29av	pgxcs-kftvmacz		PGX_AM_BS_24174329-clc-S00473	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj5s	pgxind-kftx29ax	pgxcs-kftvmafc		PGX_AM_BS_24174329-clc-S00474	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj6t	pgxind-kftx29c6	pgxcs-kftvmaqb		PGX_AM_BS_24174329-clc-S00498	adenosquamous carcinoma [lung]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj83	pgxind-kftx29dp	pgxcs-kftvmb3f		PGX_AM_BS_24174329-clc-S00531	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj8c	pgxind-kftx29e1	pgxcs-kftvmb6a		PGX_AM_BS_24174329-clc-S00581	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj8g	pgxind-kftx29e5	pgxcs-kftvmb78		PGX_AM_BS_24174329-clc-S00602	large cell neuroendocrine with small cell carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj96	pgxind-kftx29f1	pgxcs-kftvmbeo		PGX_AM_BS_24174329-clc-S00667	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj9y	pgxind-kftx29fz	pgxcs-kftvmboo		PGX_AM_BS_24174329-clc-S00692	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgja9	pgxind-kftx29gd	pgxcs-kftvmbry		PGX_AM_BS_24174329-clc-S00705	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjaj	pgxind-kftx29gp	pgxcs-kftvmbur		PGX_AM_BS_24174329-clc-S00714	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjao	pgxind-kftx29gv	pgxcs-kftvmbw5		PGX_AM_BS_24174329-clc-S00717	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjb7	pgxind-kftx29hj	pgxcs-kftvmc1t		PGX_AM_BS_24174329-clc-S00736	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjbh	pgxind-kftx29hv	pgxcs-kftvmc4l		PGX_AM_BS_24174329-clc-S00743	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjbp	pgxind-kftx29i5	pgxcs-kftvmc6x		PGX_AM_BS_24174329-clc-S00752	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjc3	pgxind-kftx29in	pgxcs-kftvmcb5		PGX_AM_BS_24174329-clc-S00772	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjcf	pgxind-kftx29j0	pgxcs-kftvmcef		PGX_AM_BS_24174329-clc-S00741	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjcl	pgxind-kftx29j8	pgxcs-kftvmcgb		PGX_AM_BS_24174329-clc-S00794	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjcv	pgxind-kftx29jk	pgxcs-kftvmcj6		PGX_AM_BS_24174329-clc-S00827	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjdn	pgxind-kftx29kh	pgxcs-kftvmcta		PGX_AM_BS_24174329-clc-S00934	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjeg	pgxind-kftx29lh	pgxcs-kftvmd1q		PGX_AM_BS_24174329-clc-S00983	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjem	pgxind-kftx29lp	pgxcs-kftvmd3l		PGX_AM_BS_24174329-clc-S00996	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjeq	pgxind-kftx29lt	pgxcs-kftvmd4j		PGX_AM_BS_24174329-clc-S01000	adenosquamous carcinoma [lung]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjev	pgxind-kftx29lz	pgxcs-kftvmd5y		PGX_AM_BS_24174329-clc-S01017	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjfe	pgxind-kftx29mo	pgxcs-kftvmdbk		PGX_AM_BS_24174329-clc-S01052	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjft	pgxind-kftx29n6	pgxcs-kftvmdfr		PGX_AM_BS_24174329-clc-S01068	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjg5	pgxind-kftx29nm	pgxcs-kftvmdjh		PGX_AM_BS_24174329-clc-S01114	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjgf	pgxind-kftx29ny	pgxcs-kftvmdm9		PGX_AM_BS_24174329-clc-S01090	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjh6	pgxind-kftx29ou	pgxcs-kftvmdtp		PGX_AM_BS_24174329-clc-S01112	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjhd	pgxind-kftx29p2	pgxcs-kftvmdvm		PGX_AM_BS_24174329-clc-S01121	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjhi	pgxind-kftx29p8	pgxcs-kftvmdz0		PGX_AM_BS_24174329-clc-S01155	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgji6	pgxind-kftx29q1	pgxcs-kftvme62		PGX_AM_BS_24174329-clc-S01145	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjj7	pgxind-kftx29ra	pgxcs-kftvmegu		PGX_AM_BS_24174329-clc-S01184	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjk3	pgxind-kftx29sf	pgxcs-kftvmeq7		PGX_AM_BS_24174329-clc-S01217	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjkd	pgxind-kftx29sr	pgxcs-kftvmet1		PGX_AM_BS_24174329-clc-S01227	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjkl	pgxind-kftx29t1	pgxcs-kftvmeve		PGX_AM_BS_24174329-clc-S01233	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjkv	pgxind-kftx29td	pgxcs-kftvmey7		PGX_AM_BS_24174329-clc-S01244	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjm9	pgxind-kftx29v1	pgxcs-kftvmfe4		PGX_AM_BS_24174329-clc-S01295	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjmd	pgxind-kftx29v7	pgxcs-kftvmffi		PGX_AM_BS_24174329-clc-S01301	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjmf	pgxind-kftx29v9	pgxcs-kftvmffz		PGX_AM_BS_24174329-clc-S01302	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjmi	pgxind-kftx29vd	pgxcs-kftvmfgx		PGX_AM_BS_24174329-clc-S01305	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjn4	pgxind-kftx29w3	pgxcs-kftvmfmy		PGX_AM_BS_24174329-clc-S01328	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjnl	pgxind-kftx29wp	pgxcs-kftvmfs3		PGX_AM_BS_24174329-clc-S01346	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjnz	pgxind-kftx29x5	pgxcs-kftvmfvv		PGX_AM_BS_24174329-clc-S01361	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjox	pgxind-kftx29yb	pgxcs-kftvmg5p		PGX_AM_BS_24174329-clc-S01403	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjoz	pgxind-kftx29yd	pgxcs-kftvmg66		PGX_AM_BS_24174329-clc-S01404	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjp1	pgxind-kftx29yf	pgxcs-kftvmg6n		PGX_AM_BS_24174329-clc-S01405	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjpe	pgxind-kftx29yv	pgxcs-kftvmgch		PGX_AM_BS_24174329-clc-S01447	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjpl	pgxind-kftx29z5	pgxcs-kftvmgey		PGX_AM_BS_24174329-clc-S01457	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjq0	pgxind-kftx29zn	pgxcs-kftvmgj7		PGX_AM_BS_24174329-clc-S01478	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjq2	pgxind-kftx29zp	pgxcs-kftvmgjo		PGX_AM_BS_24174329-clc-S01481	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjq5	pgxind-kftx29zt	pgxcs-kftvmgkn		PGX_AM_BS_24174329-clc-S01486	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjqc	pgxind-kftx2a01	pgxcs-kftvmgmk		PGX_AM_BS_24174329-clc-S01495	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjr9	pgxind-kftx2a17	pgxcs-kftvmgwd		PGX_AM_BS_24174329-clc-S01519	carcinoid [lung]	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjrr	pgxind-kftx2a1t	pgxcs-kftvmh1k		PGX_AM_BS_24174329-clc-S01533	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjsx	pgxind-kftx2a37	pgxcs-kftvmhda		PGX_AM_BS_24174329-clc-S01576	carcinoid [lung]	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjtd	pgxind-kftx2a3r	pgxcs-kftvmhk1		PGX_AM_BS_24174329-clc-S01586	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjtq	pgxind-kftx2a47	pgxcs-kftvmhns		PGX_AM_BS_24174329-clc-S01598	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjus	pgxind-kftx2a5h	pgxcs-kftvmhyj		PGX_AM_BS_24174329-clc-S01632	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjuv	pgxind-kftx2a5k	pgxcs-kftvmhzh		PGX_AM_BS_24174329-clc-S01634	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjvs	pgxind-kftx2a6o	pgxcs-kftvmi8s		PGX_AM_BS_24174329-clc-S01655	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjvz	pgxind-kftx2a6w	pgxcs-kftvmian		PGX_AM_BS_24174329-clc-S01635	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjw5	pgxind-kftx2a74	pgxcs-kftvmicj		PGX_AM_BS_24174329-clc-S01663	large cell carcinoma [lung]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjw7	pgxind-kftx2a76	pgxcs-kftvmid0		PGX_AM_BS_24174329-clc-S01664	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjwc	pgxind-kftx2a7c	pgxcs-kftvmief		PGX_AM_BS_24174329-clc-S01687	large cell carcinoma [lung]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjwr	pgxind-kftx2a7v	pgxcs-kftvmiil		PGX_AM_BS_24174329-clc-S01709	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjxh	pgxind-kftx2a8q	pgxcs-kftvmirz		PGX_AM_BS_24174329-clc-S01831	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjxr	pgxind-kftx2a93	pgxcs-kftvmiut		PGX_AM_BS_24174329-clc-S01761	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjyi	pgxind-kftx2aa0	pgxcs-kftvmj2q		PGX_AM_BS_24174329-clc-S01743	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjyk	pgxind-kftx2aa2	pgxcs-kftvmj37		PGX_AM_BS_24174329-clc-S01832	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjys	pgxind-kftx2aac	pgxcs-kftvmj5i		PGX_AM_BS_24174329-clc-S01845	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjyy	pgxind-kftx2aak	pgxcs-kftvmj7d		PGX_AM_BS_24174329-clc-S01864	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvglaz	pgxind-kftx2bx5	pgxcs-kftvmxoc		PGX_AM_BS_21684623_NSCLC-got-2106TT	Non-small cell carcinoma [lung]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnh0	pgxind-kftx2ek2	pgxcs-kftvnkvg		PGX_AM_BS_20164920_00-20T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnlm	pgxind-kftx2epv	pgxcs-kftvnmb6		PGX_AM_BS_20164920_99-32T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnom	pgxind-kftx2etj	pgxcs-kftvnn5x		PGX_AM_BS_20164920_Daffy10T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnr1	pgxind-kftx2ewi	pgxcs-kftvnnwl		PGX_AM_BS_20164920_H23	non-small cell lung carcinoma [cell line H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgobs	pgxind-kftx2fm9	pgxcs-kftvnu3c		PGX_AM_BS_20164920_SM-12YI	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgpmf	pgxind-kftx2h8k	pgxcs-kftvo86r		PGX_AM_BS_19607727_PulmSCC-27	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgyj5	pgxind-kftx2ryk	pgxcs-kftvqw51		PGX_AM_BS_NSCLC-yak-L-11	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Bursa	Turkey	TUR	40.19	29.08												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgyjd	pgxind-kftx2ryu	pgxcs-kftvqw7h		PGX_AM_BS_NSCLC-yak-L-16	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Bursa	Turkey	TUR	40.19	29.08												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvh3vs	pgxind-kftx2yn2	pgxcs-kftvsjtj		PGX_AM_BS_LuCa-AC-08	Adenocarcinoma [lung, stage III]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3wf	pgxind-kftx2ynu	pgxcs-kftvsk0b		PGX_AM_BS_LuCa-AC-22	Adenocarcinoma [lung, stage I]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3xe	pgxind-kftx2yp2	pgxcs-kftvskd5		PGX_AM_BS_LuCa-SQCC-44	Squamous cell carcinoma [stage IV]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3xp	pgxind-kftx2yph	pgxcs-kftvskgi		PGX_AM_BS_LuCa-SQCC-51	Squamous cell carcinoma [stage II]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3y2	pgxind-kftx2ypx	pgxcs-kftvskke		PGX_AM_BS_LuCa-SQCC-59	Squamous cell carcinoma [stage II]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3yd	pgxind-kftx2yq9	pgxcs-kftvskna		PGX_AM_BS_LuCa-SQCC-65	Squamous cell carcinoma [stage III]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh4xb	pgxind-kftx2zxv	pgxcs-kftvsvh4		PGX_AM_BS_AEB-14595748-AC8	Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Graz	Austria	AUT	47.07	15.45												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5iy	pgxind-kftx30os	pgxcs-kftvt263		PGX_AM_BS_NeuEndLung-N3	Large cell neuroendocrine carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh7rd	pgxind-kftx33gy	pgxcs-kftvtr60		PGX_AM_BS_SqLC-chu-L-13	Squamous cell carcinoma [T2N0]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oita	Japan	JPN	33.24	131.61												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh9ba	pgxind-kftx35et	pgxcs-kftvu8h9		PGX_AM_BS_PulAdCa-08	pulmonary adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvhb4f	pgxind-kftx37og	pgxcs-kftvussq		PGX_AM_BS_SCLC-18	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvhb4m	pgxind-kftx37oo	pgxcs-kftvusup		PGX_AM_BS_SCLC-22	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvhhnx	pgxind-kftx3fei	pgxcs-kftvwqmx		3a7c0b5f-2862-495b-81ac-16384b10490c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhhqz	pgxind-kftx3fi7	pgxcs-kftvwrl9		bbf7c533-2058-4f01-ba33-35efceac3f1c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhhv4	pgxind-kftx3fn1	pgxcs-kftvwsu7		482c1c70-ae61-45da-b1c0-4303abdda2cd	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhhzc	pgxind-kftx3frz	pgxcs-kftvwu4x		3073311b-5b00-4fd7-b1f6-1067d2e86564	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhih3	pgxind-kftx3gdi	pgxcs-kftvwzqj		aee334d0-5a07-4392-bf02-aca59066a68f	Primary Tumor	NCIT:C7269	Non-Mucinous Minimally Invasive Lung Adenocarcinoma	pgx:icdom-82523	Bronchiolo-alveolar carcinoma, non- mucinous	pgx:icdot-C34.8	Overlapping lesion of lung	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhikj	pgxind-kftx3ghj	pgxcs-kftvx0qn		57a554b7-e96b-440b-97fd-a452d06d3986	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhitc	pgxind-kftx3grt	pgxcs-kftvx3hn::pgxcs-kftvy0rt		9fcabda1-ea79-4188-8b3f-7d0fd060a819	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhj2b	pgxind-kftx3h1s	pgxcs-kftvx69d		efb52770-85f3-4854-b335-a2c750ec77d5	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhj46	pgxind-kftx3h3w	pgxcs-kftvx6t4		7310195a-bf13-4efb-a7ed-e3974b775908	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhjhc	pgxind-kftx3hje	pgxcs-kftvxay9		290bbfa2-1028-46a3-b8a4-ca7848590bbf	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhjpc	pgxind-kftx3hsh	pgxcs-kftvxde9		c336b6cd-94ea-43d5-b3fb-6b4408ccf034	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhk5m	pgxind-kftx3iao	pgxcs-kftvxigt		9ee35460-266a-485d-966d-b235fe620ccc	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkgy	pgxind-kftx3int	pgxcs-kftvxm2y		323d4a3b-38d8-4428-9135-437a839dc8e4	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkil	pgxind-kftx3iot	pgxcs-kftvxmk9		aeb9e1bc-a9d2-4aa3-8cdd-cc4edbf5edf9	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkkg	pgxind-kftx3irc	pgxcs-kftvxn3d		b5a9254a-5357-4af3-a07d-44e67173a091	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhklv	pgxind-kftx3isr	pgxcs-kftvxnky		4ed3eaec-0085-4115-bbe7-27645b6a3a8b	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhla3	pgxind-kftx3jj9	pgxcs-kftvxv5j		4083de2f-3ff5-487b-a27b-783d51c4f853	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhlpo	pgxind-kftx3jzk	pgxcs-kftvy01k		34d67358-a2ea-40f9-bb03-cd8dc9eeeb8f	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.8	Overlapping lesion of lung	lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhm4d	pgxind-kftx3kem	pgxcs-kftvy4l6		a6e8c3e6-28a4-4b3b-9785-d6f0773fa1e0	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhm8a	pgxind-kftx3kib	pgxcs-kftvy5up		17cc65cf-816c-4656-b2bf-e9889fe4c5e7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhmru	pgxind-kftx3kx2	pgxcs-kftvyc31::pgxcs-kftvz87g::pgxcs-kftw38jh		d2198941-e96f-40bd-9fbe-82886217d5db	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhn33	pgxind-kftx3lnf	pgxcs-kftvyfmp		b2a531d4-d4dd-4d33-9bc2-5f8ec2351a78	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhn7o	pgxind-kftx3jc3	pgxcs-kftvyh27		9a479d32-13a4-46c2-b26d-34cb6051a891	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhnco	pgxind-kftx3lx1	pgxcs-kftvyip8		b4d0166a-c032-4865-9b1b-d49079d2c1c1	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhned	pgxind-kftx3lyi	pgxcs-kftvyj75		9a982d6f-1006-486a-8479-3f011e8a6e49	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhnlv	pgxind-kftx3m64	pgxcs-kftvyljh		53a420fd-6e31-46ee-8ac6-b383f4305cd2	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhoon	pgxind-kftx3n5w	pgxcs-kftvyxsl		d26f13f5-b997-4068-8ae8-b127314937cc	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhowp	pgxind-kftx3nd6	pgxcs-kftvz0c1		ee851ee4-0c49-4839-8c92-9a61c5dc609e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhoyp	pgxind-kftx3nf3	pgxcs-kftvz0xa		34cf39a1-158e-4362-a487-d25c7d98a8cd	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhpc5	pgxind-kftx3nqm	pgxcs-kftvz57m		22434a49-eb8a-43ac-8c08-ae6dcbe6fbb8	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhpwq	pgxind-kftx3o9z	pgxcs-kftvzbn1		97e9d32a-d9f8-43d3-a459-9cd2bc8cd781	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhq1e	pgxind-kftx3ody	pgxcs-kftvzd3v		32bf8629-ef58-4944-ae9e-2dc4682bfb86	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhq9h	pgxind-kftx3okl	pgxcs-kftvzfo9		7ca68089-c61f-4d31-8cc8-fb11ae70910a	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqbj	pgxind-kftx3om6	pgxcs-kftvzgag		39a3dc9c-488b-4a35-b41c-7e1608e06dc7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqs1	pgxind-kftx3oyp	pgxcs-kftvzll9::pgxcs-kftw3p6y		48dd9724-8848-48c3-8628-7e78a24e3f2c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhr0d	pgxind-kftx3gnr	pgxcs-kftvzo9m		300cb22f-acb4-4acd-8d64-fe8dcdf64801	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhr0x	pgxind-kftx3p5a	pgxcs-kftvzofe		469f6b04-73e9-4259-8fda-ed1c17ef9b19	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhr3o	pgxind-kftx3p7v	pgxcs-kftvzpbg		a633a5ca-c207-45be-8903-93527de31c22	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhrjl	pgxind-kftx3pke	pgxcs-kftvzucc		b655d062-4dd8-4b88-aab9-1998499c8f7e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhrp1	pgxind-kftx3pol	pgxcs-kftvzw1a		4002e223-b5cb-4e18-8b66-c71c66040536	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhs4y	pgxind-kftx3q0h	pgxcs-kftw014u		171e69fb-ce1c-43e9-9f05-d34ebf4da682	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhs5b	pgxind-kftx3q0u	pgxcs-kftw018r		556bb046-bd81-4366-a167-e86d991ee732	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhsgs	pgxind-kftx3q8v	pgxcs-kftw04xj		5235cfa0-b767-42cd-aa9b-3bd2f0f4fb64	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhsyb	pgxind-kftx3jvb	pgxcs-kftw0amf		0ed07726-db2f-4751-a47c-adfaedfc6fd9	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtc6	pgxind-kftx3qvm	pgxcs-kftw0f07		802397ca-147b-45ae-a055-d0c3592617d2	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtm8	pgxind-kftx3r2r	pgxcs-kftw0ib6		cbf412d6-88f2-4bc0-9bf9-eae76ba6c77f	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtsl	pgxind-kftx3gbd	pgxcs-kftw0kaq		d0237729-674e-42ab-8a16-db371630edba	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtx4	pgxind-kftx3r9q	pgxcs-kftw0lqg		b0410cd6-693d-41d6-9dad-d1b1c30bf5cb	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhu2e	pgxind-kftx3rci	pgxcs-kftw0nhg		b89028a9-39e2-4f7e-9746-911414712921	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhucd	pgxind-kftx3ris	pgxcs-kftw0qmq		964f7284-f9b8-4f77-a744-7182685dc6a7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhug1	pgxind-kftx3ou7	pgxcs-kftw0rtr		d81fe19e-df9e-4d0f-b491-d139e51d7bb7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhugk	pgxind-kftx3rlt	pgxcs-kftw0rz3		43b96e20-df08-4c56-915f-5d626f90c415	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhujs	pgxind-kftx3kl5	pgxcs-kftw0t0b::pgxcs-kftw4gx3		d8f165af-1df5-4876-abf8-7596e52a3bc3	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhv1k	pgxind-kftx3rsz	pgxcs-kftw0vql		b180fdf0-935d-406a-9ec3-0d839d74d322	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvew	pgxind-kftx3rx0	pgxcs-kftw102u		11d60aed-2522-4fe0-be29-78955dc687ef	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvik	pgxind-kftx3s2r	pgxcs-kftw118g		ffc0798d-602c-495a-aa23-6a5c021ae197	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvwg	pgxind-kftx3scb	pgxcs-kftw15ks		c58243d7-77ea-4806-8298-2e322d5219a3	Primary Tumor	NCIT:C7269	Non-Mucinous Minimally Invasive Lung Adenocarcinoma	pgx:icdom-82523	Bronchiolo-alveolar carcinoma, non- mucinous	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhw4q	pgxind-kftx3r7d	pgxcs-kftw187m		1220e8b3-e16e-454e-bc49-60f49f9fe090	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhw98	pgxind-kftx3myw	pgxcs-kftw19mx		7a55a700-a706-443d-8bad-e70483c464f2	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhwa1	pgxind-kftx3sle	pgxcs-kftw19y7		03cacf37-c053-4f09-be6f-d9a51e1967a0	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhwgs	pgxind-kftx3spm	pgxcs-kftw1c20::pgxcs-kftw4r80		cdffec20-96a8-4b64-9959-f701504ad186	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhwuy	pgxind-kftx3fvs	pgxcs-kftw1gl2		ea658763-5482-44b6-a1d1-d9bb66f40092	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhww2	pgxind-kftx3l71	pgxcs-kftw1gx3		c8a10568-8ae3-4cad-b672-fb03ddad8dfc	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhx4p	pgxind-kftx3t2u	pgxcs-kftw1jph		a13b5c1e-dce0-4626-8a90-6611fa51f286	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhxan	pgxind-kftx3hae	pgxcs-kftw1lng		9babf36a-fe87-4973-a220-97c5c26b76a2	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhxo0	pgxind-kftx3ter	pgxcs-kftw1pvk		5d0e7b83-5577-450a-b1a5-59ca03fc3bc5	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhxuj	pgxind-kftx3rj4	pgxcs-kftw1s0f		d95f1517-799c-48b7-8514-d4423b881c8d	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyep	pgxind-kftx3tsn	pgxcs-kftw1yet		db809a73-5e5f-42f2-ab05-89bac944411d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyi4	pgxind-kftx3ond	pgxcs-kftw1zi5		aae346a0-532d-48a3-89b2-d0a614097fd5	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhylr	pgxind-kftx3tvm	pgxcs-kftw20nz		1d014bf1-95ae-42e3-ae39-97ff4841d8ca	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyyq	pgxind-kftx3q72	pgxcs-kftw24ud		060717ad-f034-46fa-8e9b-94a9422e4666	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyzn	pgxind-kftx3u1n	pgxcs-kftw2546		9cea4206-b460-433b-bf50-29c56cb8e33d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhz1r	pgxind-kftx3iro	pgxcs-kftw25ti		096d8008-0b37-48c2-a938-a7864cbfb66c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.8	Overlapping lesion of lung	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhz72	pgxind-kftx3i69	pgxcs-kftw27hy		5e72a9b0-5f80-462e-a586-262f573dc62c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhz9c	pgxind-kftx3oji	pgxcs-kftw2898		e63d9a32-593f-46e7-9d3b-866435cab585	Primary Tumor	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhzco	pgxind-kftx3qg9	pgxcs-kftw29d6		a0f77a32-308b-49f5-be76-7e9a6f288e9f	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhzfi	pgxind-kftx3u8y	pgxcs-kftw2a7p		4d85bf07-6762-4609-a08e-7b6a4bd2d91b	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhzhu	pgxind-kftx3tic	pgxcs-kftw2ays		21a9703e-acf2-43a8-a2e2-23158404aed8	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0an	pgxind-kftx3ulf	pgxcs-kftw2k7j		c5363830-3db9-4c0c-aa47-b32fdc888c60	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0gt	pgxind-kftx3unz	pgxcs-kftw2m7l		f9bda334-2bd7-49e8-b054-858cc335f3c5	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0qw	pgxind-kftx3urg	pgxcs-kftw2pd1		55e3df5b-60f9-4b50-9d3d-e4463e1a2c5e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0tn	pgxind-kftx3usu	pgxcs-kftw2q9p		0b2ec859-c534-4e10-a142-33518b56092c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0wx	pgxind-kftx3sr9	pgxcs-kftw2rbx		32342d96-3b04-4881-9e98-9cb63918fe48	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi18z	pgxind-kftx3osw	pgxcs-kftw2v7i		01f94091-eb70-40d3-9d56-70c4f847cb4c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi1a0	pgxind-kftx3uyp	pgxcs-kftw2vie		a29977a3-cedd-4861-a566-d4e942002ade	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi1uw	pgxind-kftx3v5y	pgxcs-kftw32al		0748861e-1332-4a53-b714-aaaa467951e6	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi26y	pgxind-kftx3mas	pgxcs-kftw365h		3e11762a-faf0-489d-8985-8ede2ccabd76	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi2ee	pgxind-kftx3tnm	pgxcs-kftw38hj		185bc9bd-1e20-467c-9c06-908c8aa27e7d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi34t	pgxind-kftx3ull	pgxcs-kftw3gwp		597d38ff-839c-4fe3-b889-efd0f680b715	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi3q5	pgxind-kftx3l0a	pgxcs-kftw3nrz		45c17476-0525-46d2-8448-48d4de6713f1	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi3rn	pgxind-kftx3sme	pgxcs-kftw3o90		02fb48a8-5d88-44e8-adcb-19424fb1f63c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi45y	pgxind-kftx3fj1	pgxcs-kftw3svw		57a0a87e-74cb-493e-a3d9-242290f29a55	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4rh	pgxind-kftx3w0k	pgxcs-kftw3zs5		3788c2e8-a8d9-41f2-bad4-43e948bd90cd	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi5cn	pgxind-kftx3lho	pgxcs-kftw46tz		c70ede8e-5761-434c-af09-8315bd688cd4	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi5fp	pgxind-kftx3mg4	pgxcs-kftw47ue		d6883cf1-e6df-4303-936a-e569b27e73b7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi5gd	pgxind-kftx3ts3	pgxcs-kftw482a		d254d457-f42f-42a1-88ff-1e05158c554e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi5gm	pgxind-kftx3w5u	pgxcs-kftw485a		31d65a90-ec60-48bb-b2e3-506327223f03	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi5mh	pgxind-kftx3npy	pgxcs-kftw4a0h		db44b283-6a6e-4827-ba6f-5fad2b723d2e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi60r	pgxind-kftx3f9b	pgxcs-kftw4elt		abc3a25f-d5bc-469e-8c3e-8e6f5b129e8f	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi61n	pgxind-kftx3szd	pgxcs-kftw4evl		c8c5aa67-c6b9-48ba-ace2-b040170d73fc	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi64r	pgxind-kftx3u7w	pgxcs-kftw4fvn		eb822f95-8b15-4c86-b5e5-b0afe9c32e0c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi64w	pgxind-kftx3wa9	pgxcs-kftw4fx4		9a7a1b22-9df6-438f-ad00-54755c7dbc7c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi659	pgxind-kftx3pc8	pgxcs-kftw4g11		bccca633-bec7-4a55-9bcd-d4a0e598ada1	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi671	pgxind-kftx3lpg	pgxcs-kftw4gk6		778481c5-9fd9-4948-9f1f-229b9569faf1	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6dc	pgxind-kftx3jyw	pgxcs-kftw4iny		ea556296-ec05-4e4f-b95e-6bf02abb4463	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6dv	pgxind-kftx3vsi	pgxcs-kftw4itt		dd9c2f71-145a-4f7f-8b64-095b1fc75c3d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6i2	pgxind-kftx3mdr	pgxcs-kftw4k6k		7f56df3f-b649-43d1-ab46-ad460233e46b	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6kc	pgxind-kftx3kd1	pgxcs-kftw4ky4::pgxcs-kftw4ojn		1028d7a9-0ac0-4fd8-a34b-46f3e6e53f79	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6u0	pgxind-kftx3ro2	pgxcs-kftw4o2e::pgxcs-kftw50gp		7f411683-9d4e-4470-9987-eeccbdf090bb	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi73s	pgxind-kftx3piu	pgxcs-kftw4rbx		7d0017c2-db42-4758-8dc4-0250ec5fd83c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7xo	pgxind-kftx3war	pgxcs-kftw50zt		8b9fadc8-a4ae-49e2-b50c-41af103782f6	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi8e4	pgxind-kftx3kl9	pgxcs-kftw569j		f65c895f-cfea-46a3-b3a0-7c8a98d7522a	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi959	pgxind-kftx3fkn	pgxcs-kftw5f14		09656581-db34-4e6e-afe0-80666eb5fba6	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9q5	pgxind-kftx3wmr	pgxcs-kftw5ioa		bac0b02d-ac3b-4784-b8bf-180eadd548a3	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9rv	pgxind-kftx3k1o	pgxcs-kftw5j7r		98687adb-f8e9-4e6e-bc1b-396a3ddfac96	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-khv36ocv	pgxind-khv36odb	pgxcs-khv36ode		PGX_AM_BS_brain20	lung carcinoma [brain metastasis]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				None	None	XXX	0.0	0.0												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidvb	pgxind-kftx41fr	pgxcs-kftw6sye		PGX_AM_BS_GSM402757	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402757	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidvp	pgxind-kftx41g7	pgxcs-kftw6t2a		PGX_AM_BS_GSM402765	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402765	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidvv	pgxind-kftx41gf	pgxcs-kftw6t48		PGX_AM_BS_GSM402769	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402769	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidwa	pgxind-kftx41gx	pgxcs-kftw6t8l		PGX_AM_BS_GSM402778	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402778	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidwf	pgxind-kftx41h3	pgxcs-kftw6ta2		PGX_AM_BS_GSM402781	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402781	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidwj	pgxind-kftx41h7	pgxcs-kftw6tb0		PGX_AM_BS_GSM402783	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402783	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidwt	pgxind-kftx41hk	pgxcs-kftw6te7		PGX_AM_BS_GSM402789	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402789	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidx1	pgxind-kftx41hu	pgxcs-kftw6tgn		PGX_AM_BS_GSM402794	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402794	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidxc	pgxind-kftx41i8	pgxcs-kftw6tj2		PGX_AM_BS_GSM402799	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402799	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieb4	pgxind-kftx41z7	pgxcs-kftw6xuy		PGX_AM_BS_GSM434253	lung adenocarcinoma [cell line NCI-H2122]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434253	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieba	pgxind-kftx41zf	pgxcs-kftw6xxe		PGX_AM_BS_GSM434258	Lung adenocarcinoma [cell line HCC1171]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434258	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviebk	pgxind-kftx41zr	pgxcs-kftw6y0l		PGX_AM_BS_GSM434264	Lung adenocarcinoma [cell line HCC78]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434264	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviebp	pgxind-kftx41zx	pgxcs-kftw6y22		PGX_AM_BS_GSM434267	Large cell lung carcinoma [cell line NCI-H157]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434267	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviec7	pgxind-kftx420j	pgxcs-kftw6y7i		PGX_AM_BS_GSM434278	Lung adenocarcinoma [cell line NCI-H1568]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434278	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviec9	pgxind-kftx420l	pgxcs-kftw6y80		PGX_AM_BS_GSM434279	lung adenocarcinoma [cell line NCI-H1755]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434279	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviecm	pgxind-kftx4211	pgxcs-kftw6yby		PGX_AM_BS_GSM434287	large cell lung carcinoma [cell line LCLC-103-H]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434287	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieco	pgxind-kftx4213	pgxcs-kftw6ycg		PGX_AM_BS_GSM434288	Large cell lung carcinoma [cell line LCLC-97TMI]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434288	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviecv	pgxind-kftx421b	pgxcs-kftw6yeg		PGX_AM_BS_GSM434292	non-small cell Lung carcinoma [cell line EKVX]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434292	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvied8	pgxind-kftx421r	pgxcs-kftw6yie		PGX_AM_BS_GSM434300	lung adenocarcinoma [cell line COLO 699]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434300	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieds	pgxind-kftx422g	pgxcs-kftw6yo9		PGX_AM_BS_GSM434312	Lung adenocarcinoma [cell line HCC1833]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434312	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviedu	pgxind-kftx422i	pgxcs-kftw6yrg		PGX_AM_BS_GSM434313	Bronchioalveolar carcinoma [cell line NCI-H1650]	NCIT:C2923	Bronchioloalveolar carcinoma	pgx:icdom-82513	Alveolar adenocarcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434313	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviedx	pgxind-kftx422m	pgxcs-kftw6ysh		PGX_AM_BS_GSM434315	Lung adenocarcinoma [cell line NCI-H1993]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434315	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieeh	pgxind-kftx423b	pgxcs-kftw6yyf		PGX_AM_BS_GSM434327	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434327	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieep	pgxind-kftx423l	pgxcs-kftw6z0u		PGX_AM_BS_GSM434332	Lung adenocarcinoma [cell line NCI-H2030]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434332	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieey	pgxind-kftx423v	pgxcs-kftw6z3a		PGX_AM_BS_GSM434787	non-small cell  lung carcinoma [cell line NCI-H1869]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434787	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvief1	pgxind-kftx423z	pgxcs-kftw6z49		PGX_AM_BS_GSM434789	squamous cell lung carcinoma [cell line NCI-H2170]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434789	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviefh	pgxind-kftx424h	pgxcs-kftw6z8m		PGX_AM_BS_GSM434798	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434798	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviefo	pgxind-kftx424q	pgxcs-kftw6zak		PGX_AM_BS_GSM434802	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434802	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieg8	pgxind-kftx425e	pgxcs-kftw6zgd		PGX_AM_BS_GSM434814	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434814	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviekb	pgxind-kftx42ah	pgxcs-kftw70pj		PGX_AM_BS_GSM169440	small cell lung carcinoma [cell line NCI-H211]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169440	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviekl	pgxind-kftx42at	pgxcs-kftw70sz		PGX_AM_BS_GSM169447	Small cell lung carcinoma [cell line SHP-77]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169447	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviez2	pgxind-kftx42sn	pgxcs-kftw75as		PGX_AM_BS_GSM242163	Lung carcinoma [cell line]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				King of Prussia	United States of America	USA	40.09	-75.4					geo:GSM242163	geo:GSE9585	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifrv	pgxind-kftx43rx	pgxcs-kftw7e2e		PGX_AM_BS_GSM449585	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449585	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifs4	pgxind-kftx43s7	pgxcs-kftw7e4s		PGX_AM_BS_GSM449590	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449590	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifsa	pgxind-kftx43sg	pgxcs-kftw7e6q		PGX_AM_BS_GSM449594	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449594	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifsc	pgxind-kftx43si	pgxcs-kftw7e78		PGX_AM_BS_GSM449595	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449595	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifse	pgxind-kftx43sk	pgxcs-kftw7e7p		PGX_AM_BS_GSM449596	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449596	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifso	pgxind-kftx43sw	pgxcs-kftw7eap		PGX_AM_BS_GSM449602	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449602	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifsv	pgxind-kftx43t4	pgxcs-kftw7ecn		PGX_AM_BS_GSM449606	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449606	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviftf	pgxind-kftx43ts	pgxcs-kftw7eii		PGX_AM_BS_GSM449618	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449618	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvig6k	pgxind-kftx449u	pgxcs-kftw7ik6		PGX_AM_BS_GSM455987	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM455987	geo:GSE18252	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvig6v	pgxind-kftx44a9	pgxcs-kftw7ino		PGX_AM_BS_GSM455994	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM455994	geo:GSE18252	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvig7s	pgxind-kftx44bd	pgxcs-kftw7ixl		PGX_AM_BS_GSM456014	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM456014	geo:GSE18252	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvih2l	pgxind-kftx45cx	pgxcs-kftw7sao		PGX_AM_BS_GSM481163	lung adenocarcinoma [cell line PC-9/GR3]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM481163	geo:GSE19388	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvih2o	pgxind-kftx45d1	pgxcs-kftw7sbo		PGX_AM_BS_GSM481165	lung adenocarcinoma [cell line PC-9/GR5]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM481165	geo:GSE19388	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvih2t	pgxind-kftx45d7	pgxcs-kftw7sd6		PGX_AM_BS_GSM481168	lung adenocarcinoma [cell line PC-9/DR2]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM481168	geo:GSE19388	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvihzu	pgxind-kftx46i8	pgxcs-kftw82mk		PGX_AM_BS_GSM308016	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308016	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvihzv	pgxind-kftx46ia	pgxcs-kftw82n2		PGX_AM_BS_GSM308021	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308021	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvihzy	pgxind-kftx46ie	pgxcs-kftw82o1		PGX_AM_BS_GSM308023	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308023	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0n	pgxind-kftx46j9	pgxcs-kftw82vc		PGX_AM_BS_GSM308471	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308471	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0w	pgxind-kftx46jj	pgxcs-kftw82xs		PGX_AM_BS_GSM308477	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308477	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0z	pgxind-kftx46jn	pgxcs-kftw82yr		PGX_AM_BS_GSM308479	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308479	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii14	pgxind-kftx46jt	pgxcs-kftw8309		PGX_AM_BS_GSM308486	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308486	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviitv	pgxind-kftx47j6	pgxcs-kftw8bvj		PGX_AM_BS_GSM353231	papillary lung adenocarcinoma [cell line NCI-H441]	NCIT:C5650	Papillary lung adenocarcinoma	pgx:icdom-82603	Papillary adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New Haven	United States of America	USA	41.31	-72.93					geo:GSM353231	geo:GSE14079	geo:GPL1998					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviity	pgxind-kftx47ja	pgxcs-kftw8bwi		PGX_AM_BS_GSM353233	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New Haven	United States of America	USA	41.31	-72.93					geo:GSM353233	geo:GSE14079	geo:GPL1998					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijp6	pgxind-kftx48lw	pgxcs-kftw8ljl		PGX_AM_BS_GSM62332	lung adenocarcinoma [cell line NCI-H2347]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62332	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijpo	pgxind-kftx48mi	pgxcs-kftw8lph		PGX_AM_BS_GSM62970	Lung adenocarcinoma [cell line HCC2450]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62970	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijpt	pgxind-kftx48mo	pgxcs-kftw8lqx		PGX_AM_BS_GSM63349	lung adenocarcinoma [cell line NCI-H3255]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM63349	geo:GSE2922	geo:GPL2616					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvipx6	pgxind-kftx4fx3	pgxcs-kftwafem		PGX_AM_BS_GSM50209	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50209	geo:GSE2520	geo:GPL2014					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvipx8	pgxind-kftx4fx6	pgxcs-kftwaff4		PGX_AM_BS_GSM50210	non-small cell Lung carcinoma [cell line EKVX]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50210	geo:GSE2520	geo:GPL2014					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvipxa	pgxind-kftx4fx8	pgxcs-kftwaffm		PGX_AM_BS_GSM50211	lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50211	geo:GSE2520	geo:GPL2014					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvipxb	pgxind-kftx4fxa	pgxcs-kftwafg3		PGX_AM_BS_GSM50212	non-small cell Lung carcinoma [cell line HOP-92]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50212	geo:GSE2520	geo:GPL2014					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviq0d	pgxind-kftx4g0z	pgxcs-kftwagf4		PGX_AM_BS_GSM50279	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50279	geo:GSE2520	geo:GPL2015					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvir81	pgxind-kftx4hik	pgxcs-kftwatub		PGX_AM_BS_GSM333000	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Amsterdam	Netherlands	NLD	52.37	4.89					geo:GSM333000	geo:GSE13191	geo:GPL2819					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvirpd	pgxind-kftx4i43	pgxcs-kftwaz82		PGX_AM_BS_GSM536265	Bronchial carcinoid	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM536265	geo:GSE21468	geo:GPL4093					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvirq5	pgxind-kftx4i52	pgxcs-kftwazhy		PGX_AM_BS_GSM536282	small cell lung cancer	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM536282	geo:GSE21468	geo:GPL4093					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvirs7	pgxind-kftx4i7l	pgxcs-kftwb03i		PGX_AM_BS_GSM536335	small cell Lung carcinoma [cell line NCI-H792]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM536335	geo:GSE21468	geo:GPL10123					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit72	pgxind-kftx4jyt	pgxcs-kftwbfrx		PGX_AM_BS_GSM511567	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511567	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit78	pgxind-kftx4jz2	pgxcs-kftwbfty		PGX_AM_BS_GSM511571	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511571	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7c	pgxind-kftx4jz6	pgxcs-kftwbfux		PGX_AM_BS_GSM511573	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511573	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7l	pgxind-kftx4jzi	pgxcs-kftwbfxv		PGX_AM_BS_GSM511579	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511579	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7n	pgxind-kftx4jzk	pgxcs-kftwbfyd		PGX_AM_BS_GSM511580	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511580	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7p	pgxind-kftx4jzm	pgxcs-kftwbfyv		PGX_AM_BS_GSM511581	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511581	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7x	pgxind-kftx4jzw	pgxcs-kftwbg1c		PGX_AM_BS_GSM511586	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511586	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit82	pgxind-kftx4k02	pgxcs-kftwbg2s		PGX_AM_BS_GSM511589	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511589	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit83	pgxind-kftx4k04	pgxcs-kftwbfsh		PGX_AM_BS_GSM511568	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511568	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit86	pgxind-kftx4k08	pgxcs-kftwbg48		PGX_AM_BS_GSM511592	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511592	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8i	pgxind-kftx4k0m	pgxcs-kftwbg7r		PGX_AM_BS_GSM511599	non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511599	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8j	pgxind-kftx4k0o	pgxcs-kftwbg88		PGX_AM_BS_GSM511600	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511600	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8l	pgxind-kftx4k0q	pgxcs-kftwbg8q		PGX_AM_BS_GSM511601	non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511601	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8o	pgxind-kftx4k0u	pgxcs-kftwbg9p		PGX_AM_BS_GSM511603	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511603	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8s	pgxind-kftx4k0y	pgxcs-kftwbgao		PGX_AM_BS_GSM511605	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511605	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8v	pgxind-kftx4k12	pgxcs-kftwbgbn		PGX_AM_BS_GSM511607	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511607	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit91	pgxind-kftx4k1b	pgxcs-kftwbgdn		PGX_AM_BS_GSM511611	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511611	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit95	pgxind-kftx4k1f	pgxcs-kftwbgem		PGX_AM_BS_GSM511613	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511613	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitg9	pgxind-kftx4ka6	pgxcs-kftwbilx		PGX_AM_BS_GSM513944	Lung adenocarcinoma [cell line NCI-H1734]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513944	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgz	pgxind-kftx4kb2	pgxcs-kftwbitu		PGX_AM_BS_GSM513960	lung adenocarcinoma [cell line NCI-H2291]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513960	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvith3	pgxind-kftx4kb6	pgxcs-kftwbiwy		PGX_AM_BS_GSM513962	non-small cell Lung carcinoma [cell line NCI-H2342]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513962	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvith4	pgxind-kftx4kb8	pgxcs-kftwbixh		PGX_AM_BS_GSM513963	lung adenocarcinoma [cell line NCI-H2347]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513963	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvith6	pgxind-kftx4kba	pgxcs-kftwbixz		PGX_AM_BS_GSM513964	lung adenocarcinoma [cell line NCI-H2405]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513964	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvith9	pgxind-kftx4kbe	pgxcs-kftwbiyy		PGX_AM_BS_GSM513966	lung adenocarcinoma [cell line NCI-H838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513966	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvithg	pgxind-kftx4kbm	pgxcs-kftwbj0w		PGX_AM_BS_GSM513970	Adenosquamous lung carcinoma [cell line NCI-H647]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513970	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitho	pgxind-kftx4kbx	pgxcs-kftwbj3d		PGX_AM_BS_GSM513975	lung adenocarcinoma [cell line NCI-H1651]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513975	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviti1	pgxind-kftx4kcc	pgxcs-kftwbj77		PGX_AM_BS_GSM513983	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513983	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitin	pgxind-kftx4kd3	pgxcs-kftwbjdg		PGX_AM_BS_GSM513996	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513996	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitio	pgxind-kftx4kd5	pgxcs-kftwbjdy		PGX_AM_BS_GSM513997	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513997	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitj9	pgxind-kftx4kdv	pgxcs-kftwbjk5		PGX_AM_BS_GSM514010	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514010	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitkk	pgxind-kftx4kfg	pgxcs-kftwbjxo		PGX_AM_BS_GSM514038	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514038	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitkn	pgxind-kftx4kfk	pgxcs-kftwbjyp		PGX_AM_BS_GSM514040	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514040	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitl2	pgxind-kftx4kg2	pgxcs-kftwbk5a		PGX_AM_BS_GSM514049	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514049	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitn7	pgxind-kftx4kiq	pgxcs-kftwbks0		PGX_AM_BS_GSM514096	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514096	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitnb	pgxind-kftx4kiu	pgxcs-kftwbksy		PGX_AM_BS_GSM514098	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514098	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitov	pgxind-kftx4kkt	pgxcs-kftwbl9a		PGX_AM_BS_GSM514132	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514132	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitow	pgxind-kftx4kkv	pgxcs-kftwbl9r		PGX_AM_BS_GSM514133	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514133	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitph	pgxind-kftx4klk	pgxcs-kftwblhk		PGX_AM_BS_GSM514145	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514145	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitqe	pgxind-kftx4kmp	pgxcs-kftwblr4		PGX_AM_BS_GSM514165	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514165	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitqm	pgxind-kftx4kmz	pgxcs-kftwbltj		PGX_AM_BS_GSM514170	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514170	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitxk	pgxind-kftx4kvd	pgxcs-kftwbnxa		PGX_AM_BS_GSM514318	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514318	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitxz	pgxind-kftx4kvv	pgxcs-kftwbo1o		PGX_AM_BS_GSM514327	Lung adenocarcinoma [cell line NCI-H1568]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514327	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityc	pgxind-kftx4kwc	pgxcs-kftwbo5k		PGX_AM_BS_GSM514335	lung adenocarcinoma [cell line NCI-H1944]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514335	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityh	pgxind-kftx4kwi	pgxcs-kftwbo71		PGX_AM_BS_GSM514338	non-small cell Lung carcinoma [cell line NCI-H2023]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514338	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu0q	pgxind-kftx4kz9	pgxcs-kftwbous		PGX_AM_BS_GSM514387	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514387	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu1j	pgxind-kftx4l0a	pgxcs-kftwbp5l		PGX_AM_BS_GSM514405	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514405	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu1n	pgxind-kftx4l0e	pgxcs-kftwbp6k		PGX_AM_BS_GSM514407	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514407	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu1o	pgxind-kftx4l0g	pgxcs-kftwbp71		PGX_AM_BS_GSM514408	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514408	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu26	pgxind-kftx4l12	pgxcs-kftwbpcb		PGX_AM_BS_GSM514419	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514419	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2e	pgxind-kftx4l1c	pgxcs-kftwbpeq		PGX_AM_BS_GSM514424	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514424	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2i	pgxind-kftx4l1g	pgxcs-kftwbpfo		PGX_AM_BS_GSM514426	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514426	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2j	pgxind-kftx4l1i	pgxcs-kftwbpg6		PGX_AM_BS_GSM514427	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514427	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2n	pgxind-kftx4l1m	pgxcs-kftwbph5		PGX_AM_BS_GSM514429	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514429	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2q	pgxind-kftx4l1q	pgxcs-kftwbpi4		PGX_AM_BS_GSM514431	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514431	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2t	pgxind-kftx4l1u	pgxcs-kftwbpj3		PGX_AM_BS_GSM514433	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514433	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu3f	pgxind-kftx4l2j	pgxcs-kftwbppd		PGX_AM_BS_GSM514446	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514446	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu3j	pgxind-kftx4l2p	pgxcs-kftwbpqt		PGX_AM_BS_GSM514449	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514449	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu3y	pgxind-kftx4l36	pgxcs-kftwbpv5		PGX_AM_BS_GSM514458	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514458	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu55	pgxind-kftx4l4h	pgxcs-kftwbq9s		PGX_AM_BS_GSM514484	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514484	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu5l	pgxind-kftx4l50	pgxcs-kftwbqen		PGX_AM_BS_GSM514494	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514494	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu7b	pgxind-kftx4l73	pgxcs-kftwbqx5		PGX_AM_BS_GSM514532	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514532	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu7e	pgxind-kftx4l76	pgxcs-kftwbqy4		PGX_AM_BS_GSM514534	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514534	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu7q	pgxind-kftx4l7k	pgxcs-kftwbr1g		PGX_AM_BS_GSM514541	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514541	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu7x	pgxind-kftx4l7s	pgxcs-kftwbr3e		PGX_AM_BS_GSM514545	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514545	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu8d	pgxind-kftx4l8c	pgxcs-kftwbr88		PGX_AM_BS_GSM514555	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514555	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu8i	pgxind-kftx4l8i	pgxcs-kftwbr9o		PGX_AM_BS_GSM514558	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514558	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu8l	pgxind-kftx4l8m	pgxcs-kftwbran		PGX_AM_BS_GSM514560	lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514560	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu8n	pgxind-kftx4l8o	pgxcs-kftwbrb5		PGX_AM_BS_GSM514561	squamous cell lung carcinoma [cell line SK-MES-1]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514561	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviuiw	pgxind-kftx4ll6	pgxcs-kftwbug1		PGX_AM_BS_GSM517071	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM517071	geo:GSE20584	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvix9h	pgxind-kftx4oyv	pgxcs-kftwcoy5		PGX_AM_BS_GSM638959	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638959	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvix9l	pgxind-kftx4oyz	pgxcs-kftwcowo		PGX_AM_BS_GSM638956	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638956	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixa3	pgxind-kftx4ozl	pgxcs-kftwcp2k		PGX_AM_BS_GSM638968	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638968	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixax	pgxind-kftx4p0m	pgxcs-kftwcpbe		PGX_AM_BS_GSM638988	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638988	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixay	pgxind-kftx4p0o	pgxcs-kftwcpbw		PGX_AM_BS_GSM638989	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638989	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixb0	pgxind-kftx4p0r	pgxcs-kftwcpce		PGX_AM_BS_GSM638990	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638990	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixb3	pgxind-kftx4p0v	pgxcs-kftwcpde		PGX_AM_BS_GSM638992	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638992	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixbr	pgxind-kftx4p1n	pgxcs-kftwcpk9		PGX_AM_BS_GSM639006	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639006	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixc1	pgxind-kftx4p1z	pgxcs-kftwcpn6		PGX_AM_BS_GSM639012	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639012	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixc9	pgxind-kftx4p29	pgxcs-kftwcppm		PGX_AM_BS_GSM639017	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639017	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixcg	pgxind-kftx4p2h	pgxcs-kftwcprk		PGX_AM_BS_GSM639021	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639021	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixci	pgxind-kftx4p2j	pgxcs-kftwcps2		PGX_AM_BS_GSM639022	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639022	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixcj	pgxind-kftx4p2l	pgxcs-kftwcpsj		PGX_AM_BS_GSM639023	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639023	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixdr	pgxind-kftx4p45	pgxcs-kftwcq84		PGX_AM_BS_GSM639050	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639050	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixe0	pgxind-kftx4p4f	pgxcs-kftwcqal		PGX_AM_BS_GSM639055	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639055	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixea	pgxind-kftx4p4r	pgxcs-kftwcqdj		PGX_AM_BS_GSM639061	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639061	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixeb	pgxind-kftx4p4t	pgxcs-kftwcqe0		PGX_AM_BS_GSM639062	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639062	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixew	pgxind-kftx4p5j	pgxcs-kftwcqkk		PGX_AM_BS_GSM639075	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639075	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixey	pgxind-kftx4p5l	pgxcs-kftwcql2		PGX_AM_BS_GSM639076	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639076	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixf5	pgxind-kftx4p5t	pgxcs-kftwcqn1		PGX_AM_BS_GSM639080	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639080	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixfd	pgxind-kftx4p64	pgxcs-kftwcqpk		PGX_AM_BS_GSM639085	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639085	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixfl	pgxind-kftx4p6e	pgxcs-kftwcqs3		PGX_AM_BS_GSM639090	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639090	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixfn	pgxind-kftx4p6g	pgxcs-kftwcqsm		PGX_AM_BS_GSM639091	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639091	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixft	pgxind-kftx4p6o	pgxcs-kftwcqun		PGX_AM_BS_GSM639095	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639095	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixg1	pgxind-kftx4p6y	pgxcs-kftwcqx7		PGX_AM_BS_GSM639100	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639100	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixg3	pgxind-kftx4p70	pgxcs-kftwcqxq		PGX_AM_BS_GSM639101	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639101	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixg5	pgxind-kftx4p72	pgxcs-kftwcqy8		PGX_AM_BS_GSM639102	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639102	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixgh	pgxind-kftx4p7g	pgxcs-kftwcr1p		PGX_AM_BS_GSM639109	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639109	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixh9	pgxind-kftx4p8f	pgxcs-kftwcrc9		PGX_AM_BS_GSM639126	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639126	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixhb	pgxind-kftx4p8h	pgxcs-kftwcrcr		PGX_AM_BS_GSM639127	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639127	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixhf	pgxind-kftx4p8n	pgxcs-kftwcre8		PGX_AM_BS_GSM639130	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639130	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixhk	pgxind-kftx4p8t	pgxcs-kftwcrfp		PGX_AM_BS_GSM639133	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639133	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixho	pgxind-kftx4p8x	pgxcs-kftwcrgp		PGX_AM_BS_GSM639135	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639135	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixhx	pgxind-kftx4p9a	pgxcs-kftwcrj6		PGX_AM_BS_GSM639141	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639141	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixic	pgxind-kftx4p9r	pgxcs-kftwcro4		PGX_AM_BS_GSM639152	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639152	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixis	pgxind-kftx4pab	pgxcs-kftwcrt2		PGX_AM_BS_GSM639162	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639162	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixj2	pgxind-kftx4pan	pgxcs-kftwcrw1		PGX_AM_BS_GSM639168	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639168	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixjc	pgxind-kftx4paz	pgxcs-kftwcrz1		PGX_AM_BS_GSM639174	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639174	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixjf	pgxind-kftx4pb3	pgxcs-kftwcs01		PGX_AM_BS_GSM639176	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639176	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixjh	pgxind-kftx4pb5	pgxcs-kftwcs0i		PGX_AM_BS_GSM639177	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639177	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizj6	pgxind-kftx4reu	pgxcs-kftwdb02		PGX_AM_BS_GSM303896	lung adenocarcinoma [cell line NCI-H2347]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM303896	geo:GSE12019	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3io	pgxind-kftx4wb8	pgxcs-kftwejge		PGX_AM_BS_GSM827200	squamous cell lung carcinoma [cell line VMRC-LCP]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827200	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3py	pgxind-kftx4wvb	pgxcs-kftwelq0		PGX_AM_BS_GSM827359	Bronchioalveolar carcinoma [cell line NCI-H1781]	NCIT:C2923	Bronchioloalveolar carcinoma	pgx:icdom-82513	Alveolar adenocarcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827359	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3q1	pgxind-kftx4wvf	pgxcs-kftwelr0		PGX_AM_BS_GSM827361	non-small cell Lung carcinoma [cell line NCI-H1435]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827361	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3qw	pgxind-kftx4wwi	pgxcs-kftwem2c		PGX_AM_BS_GSM827380	small cell Lung carcinoma [cell line STC1]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827380	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3vk	pgxind-kftx4x27	pgxcs-kftweni6		PGX_AM_BS_GSM827481	lung adenocarcinoma [cell line NCI-H650]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827481	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3vn	pgxind-kftx4x2b	pgxcs-kftwenj5		PGX_AM_BS_GSM827483	Lung adenocarcinoma [cell line NCI-H1437]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827483	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3vs	pgxind-kftx4x2i	pgxcs-kftwenkm		PGX_AM_BS_GSM827486	lung adenocarcinoma [cell line NCI-H1944]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827486	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3w2	pgxind-kftx4x2u	pgxcs-kftwennk		PGX_AM_BS_GSM827492	lung adenocarcinoma [cell line 201T]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827492	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3ws	pgxind-kftx4x3o	pgxcs-kftwenuw		PGX_AM_BS_GSM827507	Lung adenocarcinoma [cell line NCI-H1734]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827507	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3wt	pgxind-kftx4x3q	pgxcs-kftwenk4		PGX_AM_BS_GSM827485	squamous cell lung carcinoma [cell line NCI-H1703]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827485	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3xv	pgxind-kftx4x4z	pgxcs-kftweo67		PGX_AM_BS_GSM827530	Lung adenocarcinoma [cell line NCI-H1573]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827530	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3yr	pgxind-kftx4x61	pgxcs-kftweofn		PGX_AM_BS_GSM827549	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827549	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3z6	pgxind-kftx4x6k	pgxcs-kftweomc		PGX_AM_BS_GSM827558	lung adenocarcinoma [cell line NCI-H1755]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827558	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj401	pgxind-kftx4x7o	pgxcs-kftweovo		PGX_AM_BS_GSM827577	squamous cell lung carcinoma [cell line LOU-NH91]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827577	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj405	pgxind-kftx4x7s	pgxcs-kftweowp		PGX_AM_BS_GSM827579	Bronchioalveolar carcinoma [cell line NCI-H1666]	NCIT:C2923	Bronchioloalveolar carcinoma	pgx:icdom-82513	Alveolar adenocarcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827579	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj4gk	pgxind-kftx4xrs	pgxcs-kftwetz1		PGX_AM_BS_GSM645857	Lung adenocarcinoma [cell line NCI-H1395]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM645857	geo:GSE26302	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj578	pgxind-kftx4yoh	pgxcs-kftwf22v		PGX_AM_BS_GSM707435	lung adenocarcinoma [short-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707435	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj57c	pgxind-kftx4yol	pgxcs-kftwf23u		PGX_AM_BS_GSM707437	lung adenocarcinoma [long-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707437	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj586	pgxind-kftx4ypl	pgxcs-kftwf2eq		PGX_AM_BS_GSM707455	squamous cell lung carcinoma [long-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707455	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj587	pgxind-kftx4ypn	pgxcs-kftwf2f8		PGX_AM_BS_GSM707456	Lung carcinoma [large-cell carcinoma, short-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707456	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj592	pgxind-kftx4yqo	pgxcs-kftwf2o2		PGX_AM_BS_GSM707474	lung adenocarcinoma [short-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707474	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj59a	pgxind-kftx4yqy	pgxcs-kftwf2qh		PGX_AM_BS_GSM707480	squamous cell lung carcinoma [short-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707480	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5a7	pgxind-kftx4ys2	pgxcs-kftwf307		PGX_AM_BS_GSM707509	squamous cell lung carcinoma [long-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707509	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5ax	pgxind-kftx4ysz	pgxcs-kftwf37z		PGX_AM_BS_GSM707526	lung adenocarcinoma [short-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707526	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5az	pgxind-kftx4yt1	pgxcs-kftwf38h		PGX_AM_BS_GSM707528	Lung carcinoma [large-cell carcinoma, long-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707528	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5b2	pgxind-kftx4yt5	pgxcs-kftwf39g		PGX_AM_BS_GSM707531	squamous cell lung carcinoma [short-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707531	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5ba	pgxind-kftx4ytg	pgxcs-kftwf3bw		PGX_AM_BS_GSM707536	squamous cell lung carcinoma [long-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707536	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5bc	pgxind-kftx4yti	pgxcs-kftwf316		PGX_AM_BS_GSM707511	squamous cell lung carcinoma [short-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707511	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5p2	pgxind-kftx4zah	pgxcs-kftwf7ml		PGX_AM_BS_GSM749532	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM749532	geo:GSE30255	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6eh	pgxind-kftx505p	pgxcs-kftwffio		PGX_AM_BS_GSM825051	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825051	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6ek	pgxind-kftx505t	pgxcs-kftwffjo		PGX_AM_BS_GSM825053	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825053	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6ey	pgxind-kftx5069	pgxcs-kftwffpm		PGX_AM_BS_GSM825063	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825063	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6f2	pgxind-kftx506f	pgxcs-kftwffr3		PGX_AM_BS_GSM825067	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825067	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6ge	pgxind-kftx5082	pgxcs-kftwfg55		PGX_AM_BS_GSM825097	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825097	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6os	pgxind-kftx50ic	pgxcs-kftwfiow		PGX_AM_BS_GSM837647	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837647	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6ps	pgxind-kftx50jk	pgxcs-kftwfizl		PGX_AM_BS_GSM837670	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837670	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6qa	pgxind-kftx50k7	pgxcs-kftwfj4x		PGX_AM_BS_GSM837681	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837681	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6qt	pgxind-kftx50kv	pgxcs-kftwfjas		PGX_AM_BS_GSM837693	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837693	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6r1	pgxind-kftx50l6	pgxcs-kftwfjez		PGX_AM_BS_GSM837698	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837698	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6s0	pgxind-kftx50mc	pgxcs-kftwfjp8		PGX_AM_BS_GSM837719	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837719	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6sb	pgxind-kftx50mq	pgxcs-kftwfjsm		PGX_AM_BS_GSM837775	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837775	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6sn	pgxind-kftx50n5	pgxcs-kftwfjw0		PGX_AM_BS_GSM837782	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837782	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6ss	pgxind-kftx50nb	pgxcs-kftwfjxg		PGX_AM_BS_GSM837785	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837785	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6sv	pgxind-kftx50nf	pgxcs-kftwfjyg		PGX_AM_BS_GSM837787	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837787	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6tp	pgxind-kftx50og	pgxcs-kftwfk76		PGX_AM_BS_GSM837805	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837805	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6tz	pgxind-kftx50os	pgxcs-kftwfka4		PGX_AM_BS_GSM837811	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837811	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6u5	pgxind-kftx50p0	pgxcs-kftwfkc2		PGX_AM_BS_GSM837815	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837815	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6ub	pgxind-kftx50p8	pgxcs-kftwfke0		PGX_AM_BS_GSM837819	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837819	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6vc	pgxind-kftx50qg	pgxcs-kftwfkq9		PGX_AM_BS_GSM837841	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837841	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6vm	pgxind-kftx50qt	pgxcs-kftwfkt7		PGX_AM_BS_GSM837847	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837847	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6w8	pgxind-kftx50rl	pgxcs-kftwfl01		PGX_AM_BS_GSM837861	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837861	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6x8	pgxind-kftx50ss	pgxcs-kftwfla8		PGX_AM_BS_GSM837882	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837882	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6xp	pgxind-kftx50td	pgxcs-kftwflf4		PGX_AM_BS_GSM837909	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837909	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6xv	pgxind-kftx50tl	pgxcs-kftwflh2		PGX_AM_BS_GSM837943	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837943	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6yw	pgxind-kftx50uu	pgxcs-kftwflrz		PGX_AM_BS_GSM837965	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837965	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7ee	pgxind-kftx51dh	pgxcs-kftwfqjs		PGX_AM_BS_GSM889587	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889587	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7eu	pgxind-kftx51e1	pgxcs-kftwfqoq		PGX_AM_BS_GSM889607	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889607	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7fe	pgxind-kftx51ep	pgxcs-kftwfqwg		PGX_AM_BS_GSM889623	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889623	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7fi	pgxind-kftx51et	pgxcs-kftwfqxe		PGX_AM_BS_GSM889626	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889626	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7gi	pgxind-kftx51g1	pgxcs-kftwfr82		PGX_AM_BS_GSM889657	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889657	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7hf	pgxind-kftx51h6	pgxcs-kftwfrhp		PGX_AM_BS_GSM889677	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889677	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7hm	pgxind-kftx51he	pgxcs-kftwfrjn		PGX_AM_BS_GSM889681	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889681	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7hr	pgxind-kftx51hl	pgxcs-kftwfrl3		PGX_AM_BS_GSM889684	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889684	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7i9	pgxind-kftx51i7	pgxcs-kftwfrqh		PGX_AM_BS_GSM889695	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889695	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7ij	pgxind-kftx51ij	pgxcs-kftwfrtf		PGX_AM_BS_GSM889701	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889701	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj87u	pgxind-kftx52dn	pgxcs-kftwfzop		PGX_AM_BS_GSM979219	Non-Small Cell Lung carcinoma [KRASpos]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979219	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj88j	pgxind-kftx52ei	pgxcs-kftwfzw5		PGX_AM_BS_GSM979234	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979234	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj88l	pgxind-kftx52ek	pgxcs-kftwfzwn		PGX_AM_BS_GSM979235	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979235	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj88t	pgxind-kftx52eu	pgxcs-kftwfzz2		PGX_AM_BS_GSM979240	Non-Small Cell Lung carcinoma [KRASpos]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979240	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj89q	pgxind-kftx52fy	pgxcs-kftwg08z		PGX_AM_BS_GSM979260	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979260	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8a2	pgxind-kftx52gc	pgxcs-kftwg0cg		PGX_AM_BS_GSM979267	Non-Small Cell Lung carcinoma [KRASpos]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979267	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8aa	pgxind-kftx52gm	pgxcs-kftwg0ew		PGX_AM_BS_GSM979272	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979272	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ac	pgxind-kftx52gn	pgxcs-kftwg0ff		PGX_AM_BS_GSM979273	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979273	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8b3	pgxind-kftx52hj	pgxcs-kftwg0nc		PGX_AM_BS_GSM979289	Non-Small Cell Lung carcinoma [KRASpos]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979289	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8c2	pgxind-kftx52iq	pgxcs-kftwg105		PGX_AM_BS_GSM979310	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979310	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ca	pgxind-kftx52j0	pgxcs-kftwg12l		PGX_AM_BS_GSM979315	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979315	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ci	pgxind-kftx52ja	pgxcs-kftwg152		PGX_AM_BS_GSM979320	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979320	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8cn	pgxind-kftx52jg	pgxcs-kftwg16k		PGX_AM_BS_GSM979323	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979323	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8cu	pgxind-kftx52jo	pgxcs-kftwg18j		PGX_AM_BS_GSM979327	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979327	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8d3	pgxind-kftx52k0	pgxcs-kftwg1bj		PGX_AM_BS_GSM979333	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979333	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ds	pgxind-kftx52kv	pgxcs-kftwg1ix		PGX_AM_BS_GSM979348	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979348	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8e7	pgxind-kftx52ld	pgxcs-kftwg1c0		PGX_AM_BS_GSM979334	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979334	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ey	pgxind-kftx52ma	pgxcs-kftwg1vx		PGX_AM_BS_GSM979374	Non-Small Cell Lung carcinoma [KRASpos]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979374	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8f0	pgxind-kftx52mc	pgxcs-kftwg1we		PGX_AM_BS_GSM979375	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979375	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8fd	pgxind-kftx52ms	pgxcs-kftwg21j		PGX_AM_BS_GSM986171	small cell lung carcinoma [cell line NCI-H211]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986171	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqa	pgxind-kftx5ba6	pgxcs-kftwi8dg		PGX_AM_BS_GSM720234	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720234	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqw	pgxind-kftx5baw	pgxcs-kftwi8ju		PGX_AM_BS_GSM720247	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720247	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfrb	pgxind-kftx5bbe	pgxcs-kftwi8oa		PGX_AM_BS_GSM720256	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720256	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfsf	pgxind-kftx5bcr	pgxcs-kftwi8os		PGX_AM_BS_GSM720257	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720257	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfsh	pgxind-kftx5bct	pgxcs-kftwi90k		PGX_AM_BS_GSM720281	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720281	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfsu	pgxind-kftx5bd9	pgxcs-kftwi94i		PGX_AM_BS_GSM720289	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720289	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjft5	pgxind-kftx5bdo	pgxcs-kftwi97w		PGX_AM_BS_GSM720296	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720296	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgbr	pgxind-kftx5c0y	pgxcs-kftwif0w		PGX_AM_BS_GSM782028	Bronchiolo-alveolar adenocarcinoma	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782028	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgcc	pgxind-kftx5c1o	pgxcs-kftwif7a		PGX_AM_BS_GSM782056	Bronchiolo-alveolar adenocarcinoma	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782056	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgdr	pgxind-kftx5c3f	pgxcs-kftwifob		PGX_AM_BS_GSM782087	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782087	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjge5	pgxind-kftx5c3y	pgxcs-kftwifsp		PGX_AM_BS_GSM782096	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782096	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgec	pgxind-kftx5c47	pgxcs-kftwifun		PGX_AM_BS_GSM782100	Bronchiolo-alveolar adenocarcinoma	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782100	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgef	pgxind-kftx5c4b	pgxcs-kftwifvm		PGX_AM_BS_GSM782102	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782102	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgey	pgxind-kftx5c50	pgxcs-kftwig1g		PGX_AM_BS_GSM782114	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782114	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggr	pgxind-kftx5c78	pgxcs-kftwigk9		PGX_AM_BS_GSM794788	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794788	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggs	pgxind-kftx5c7a	pgxcs-kftwigkq		PGX_AM_BS_GSM794789	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794789	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggw	pgxind-kftx5c7e	pgxcs-kftwiglp		PGX_AM_BS_GSM794791	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794791	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgh7	pgxind-kftx5c7s	pgxcs-kftwigrb		PGX_AM_BS_GSM794798	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794798	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgha	pgxind-kftx5c7w	pgxcs-kftwigsd		PGX_AM_BS_GSM794800	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794800	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghe	pgxind-kftx5c80	pgxcs-kftwigtd		PGX_AM_BS_GSM794802	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794802	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghx	pgxind-kftx5c8p	pgxcs-kftwigz7		PGX_AM_BS_GSM794814	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794814	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgiy	pgxind-kftx5c9y	pgxcs-kftwiha1		PGX_AM_BS_GSM794836	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794836	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgj1	pgxind-kftx5ca2	pgxcs-kftwihb0		PGX_AM_BS_GSM794838	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794838	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjida	pgxind-kftx5ek5	pgxcs-kftwj1y4		PGX_AM_BS_GSM788673	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788673	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjidb	pgxind-kftx5ek7	pgxcs-kftwj1ym		PGX_AM_BS_GSM788674	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788674	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjidx	pgxind-kftx5ekx	pgxcs-kftwj253		PGX_AM_BS_GSM788687	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788687	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjied	pgxind-kftx5elh	pgxcs-kftwj2a6		PGX_AM_BS_GSM788697	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788697	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjigc	pgxind-kftx5enx	pgxcs-kftwj2ur		PGX_AM_BS_GSM788740	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788740	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjigo	pgxind-kftx5eob	pgxcs-kftwj2y4		PGX_AM_BS_GSM788747	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788747	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjii9	pgxind-kftx5eqb	pgxcs-kftwj3h0		PGX_AM_BS_GSM788782	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788782	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjiib	pgxind-kftx5eqd	pgxcs-kftwj3hh		PGX_AM_BS_GSM788783	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788783	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjijw	pgxind-kftx5esb	pgxcs-kftwj3y9		PGX_AM_BS_GSM788818	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788818	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjik0	pgxind-kftx5esf	pgxcs-kftwj3z8		PGX_AM_BS_GSM788820	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788820	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjil8	pgxind-kftx5etx	pgxcs-kftwj4eb		PGX_AM_BS_GSM788847	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788847	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjiol	pgxind-kftx5ey4	pgxcs-kftwj5e2		PGX_AM_BS_GSM788921	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788921	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjiop	pgxind-kftx5eya	pgxcs-kftwj5fj		PGX_AM_BS_GSM788924	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788924	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhb	pgxind-kftx5fxl	pgxcs-kftwjed8		PGX_AM_BS_GSM1857255	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857255	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhj	pgxind-kftx5fxv	pgxcs-kftwjer3		PGX_AM_BS_GSM1857283	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857283	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhk	pgxind-kftx5fxx	pgxcs-kftwjerl		PGX_AM_BS_GSM1857284	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857284	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji1	pgxind-kftx5fyh	pgxcs-kftwjewi		PGX_AM_BS_GSM1857294	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857294	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji4	pgxind-kftx5fyl	pgxcs-kftwjee8		PGX_AM_BS_GSM1857257	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857257	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji5	pgxind-kftx5fyn	pgxcs-kftwjeeq		PGX_AM_BS_GSM1857258	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857258	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji9	pgxind-kftx5fyr	pgxcs-kftwjefq		PGX_AM_BS_GSM1857260	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857260	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjip	pgxind-kftx5fzc	pgxcs-kftwjekr		PGX_AM_BS_GSM1857270	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857270	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjiw	pgxind-kftx5fzk	pgxcs-kftwjemp		PGX_AM_BS_GSM1857274	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857274	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjjm	pgxind-kftx5g0g	pgxcs-kftwjf2h		PGX_AM_BS_GSM1857306	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857306	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjk6	pgxind-kftx5g15	pgxcs-kftwjfjh		PGX_AM_BS_GSM1526628	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526628	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjkd	pgxind-kftx5g1d	pgxcs-kftwjfoa		PGX_AM_BS_GSM1526638	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526638	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjkg	pgxind-kftx5g1h	pgxcs-kftwjfor		PGX_AM_BS_GSM1526639	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526639	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjl6	pgxind-kftx5g2d	pgxcs-kftwjg3c		PGX_AM_BS_GSM1526671	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526671	geo:GSE62407	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjlb	pgxind-kftx5g2j	pgxcs-kftwjg2u		PGX_AM_BS_GSM1526669	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526669	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjlx	pgxind-kftx5g3c	pgxcs-kftwjfv0		PGX_AM_BS_GSM1526652	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526652	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjm4	pgxind-kftx5g3k	pgxcs-kftwjfpq		PGX_AM_BS_GSM1526641	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526641	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjn4	pgxind-kftx5g4t	pgxcs-kftwjg6q		PGX_AM_BS_GSM925740	lung adenocarcinoma [cell line PC-9/WZR10]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM925740	geo:GSE37698	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1g	pgxind-kftx5rbv	pgxcs-kftwm848		PGX_AM_BS_GSM1181254	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181254	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1p	pgxind-kftx5rc7	pgxcs-kftwm8rc		PGX_AM_BS_GSM1181314	lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181314	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1r	pgxind-kftx5rc9	pgxcs-kftwm93x		PGX_AM_BS_GSM1181344	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181344	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt25	pgxind-kftx5rcs	pgxcs-kftwm85f		PGX_AM_BS_GSM1181257	non-small cell Lung carcinoma [cell line HOP-92]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181257	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt55	pgxind-kftx5rgi	pgxcs-kftwm9np		PGX_AM_BS_GSM750789	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM750789	geo:GSE30291	geo:GPL13786					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt63	pgxind-kftx5rhp	pgxcs-kftwm9w1		PGX_AM_BS_GSM750810	non-small cell Lung carcinoma [cell line EKVX]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM750810	geo:GSE30291	geo:GPL13786					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt8o	pgxind-kftx5rky	pgxcs-kftwmajy		PGX_AM_BS_GSM799341	Lung adenocarcinoma [cell line NCI-H23]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				NCI-H23	geo:GSM799341	geo:GSE32264	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt9a	pgxind-kftx5rlp	pgxcs-kftwmakf		PGX_AM_BS_GSM799342	Minimally invasive lung adenocarcinoma [cell line NCI-H322M]	NCIT:C2923	Bronchioloalveolar carcinoma	pgx:icdom-82513	Alveolar adenocarcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				NCI-H322M	geo:GSM799342	geo:GSE32264	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjtek	pgxind-kftx5rs7	pgxcs-kftwmcam		PGX_AM_BS_GSM1086289	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Muenster	Germany	DEU	51.96	7.63					geo:GSM1086289	geo:GSE44549	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjtel	pgxind-kftx5rs9	pgxcs-kftwmcb0		PGX_AM_BS_GSM1086290	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Muenster	Germany	DEU	51.96	7.63					geo:GSM1086290	geo:GSE44549	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjtr8	pgxind-kftx5s7u	pgxcs-kftwmfgi		PGX_AM_BS_GSM784253	Large cell lung carcinoma [cell line NCI-H1299]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784253	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuje	pgxind-kftx5t6m	pgxcs-kftwmls3		PGX_AM_BS_GSM784237	Large cell lung carcinoma [cell line NCI-H292]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784237	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjumh	pgxind-kftx5tad	pgxcs-kftwmmf0		PGX_AM_BS_GSM784226	lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784226	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjutk	pgxind-kftx5tj1	pgxcs-kftwmo6r		PGX_AM_BS_GSM784240	large cell lung carcinoma [cell line LCLC-103-H]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784240	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuu7	pgxind-kftx5tju	pgxcs-kftwmoci		PGX_AM_BS_GSM784208	Lung adenocarcinoma [cell line NCI-H1437]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784208	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuu9	pgxind-kftx5tjw	pgxcs-kftwmocw		PGX_AM_BS_GSM784247	small cell Lung carcinoma [cell line NCI-H146]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784247	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuua	pgxind-kftx5tjy	pgxcs-kftwmodb		PGX_AM_BS_GSM784195	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784195	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuuj	pgxind-kftx5tk8	pgxcs-kftwmohs		PGX_AM_BS_GSM784269	Lung adenocarcinoma [cell line NCI-H1693]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784269	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuuk	pgxind-kftx5tka	pgxcs-kftwmoi7		PGX_AM_BS_GSM784217	squamous cell lung carcinoma [cell line NCI-H1703]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784217	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuuz	pgxind-kftx5tks	pgxcs-kftwmolt		PGX_AM_BS_GSM784272	Lung adenocarcinoma [cell line NCI-H2030]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784272	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuv4	pgxind-kftx5tky	pgxcs-kftwmon1		PGX_AM_BS_GSM784209	small cell lung carcinoma [cell line NCI-H211]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784209	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuvc	pgxind-kftx5tl9	pgxcs-kftwmop2		PGX_AM_BS_GSM784201	lung adenocarcinoma [cell line NCI-H2347]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784201	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuvy	pgxind-kftx5tlz	pgxcs-kftwmouj		PGX_AM_BS_GSM784213	Adenosquamous lung carcinoma [cell line NCI-H647]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784213	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuw8	pgxind-kftx5tma	pgxcs-kftwmox0		PGX_AM_BS_GSM784220	small cell Lung carcinoma [cell line NCI-H82]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784220	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuwb	pgxind-kftx5tme	pgxcs-kftwmoxu		PGX_AM_BS_GSM784196	lung adenocarcinoma [cell line NCI-H838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784196	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuxj	pgxind-kftx5tnw	pgxcs-kftwmp69		PGX_AM_BS_GSM784255	squamous cell lung carcinoma [cell line SW900]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784255	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjv64	pgxind-kftx5tyb	pgxcs-kftwmr26		PGX_AM_BS_GSM784280	squamous cell lung carcinoma [cell line LC-1sq]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784280	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjvmv	pgxind-kftx5uiw	pgxcs-kftwmuwf		PGX_AM_BS_GSM784285	squamous cell lung carcinoma [cell line 273T]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784285	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2ve	pgxind-kftx630t	pgxcs-kftwohtd		PGX_AM_BS_GSM842553	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842553	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2vj	pgxind-kftx630z	pgxcs-kftwohua		PGX_AM_BS_GSM842556	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842556	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2vt	pgxind-kftx631c	pgxcs-kftwohw4		PGX_AM_BS_GSM842562	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842562	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2vv	pgxind-kftx631e	pgxcs-kftwohwf		PGX_AM_BS_GSM842563	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842563	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2x3	pgxind-kftx632x	pgxcs-kftwoi4o		PGX_AM_BS_GSM842590	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842590	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2x5	pgxind-kftx632z	pgxcs-kftwoi4z		PGX_AM_BS_GSM842591	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842591	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2xv	pgxind-kftx633v	pgxcs-kftwoi9y		PGX_AM_BS_GSM842607	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842607	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2yi	pgxind-kftx634o	pgxcs-kftwoied		PGX_AM_BS_GSM842621	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842621	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2yp	pgxind-kftx634w	pgxcs-kftwoifn		PGX_AM_BS_GSM842625	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842625	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2z3	pgxind-kftx635e	pgxcs-kftwoiii		PGX_AM_BS_GSM842634	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842634	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2z8	pgxind-kftx635k	pgxcs-kftwoijg		PGX_AM_BS_GSM842637	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842637	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2zm	pgxind-kftx6360	pgxcs-kftwoilx		PGX_AM_BS_GSM842645	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842645	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2zs	pgxind-kftx6367	pgxcs-kftwoin6		PGX_AM_BS_GSM842649	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842649	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk307	pgxind-kftx636p	pgxcs-kftwoiq1		PGX_AM_BS_GSM842658	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842658	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk30h	pgxind-kftx6372	pgxcs-kftwoiva		PGX_AM_BS_GSM842664	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842664	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk31m	pgxind-kftx638g	pgxcs-kftwoj2z		PGX_AM_BS_GSM842689	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842689	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk325	pgxind-kftx6394	pgxcs-kftwoj6o		PGX_AM_BS_GSM842701	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842701	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk32r	pgxind-kftx639v	pgxcs-kftwojao		PGX_AM_BS_GSM842714	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842714	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk32s	pgxind-kftx639x	pgxcs-kftwojaz		PGX_AM_BS_GSM842715	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842715	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk34p	pgxind-kftx63c8	pgxcs-kftwojnn		PGX_AM_BS_GSM842756	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842756	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk34s	pgxind-kftx63cc	pgxcs-kftwojo9		PGX_AM_BS_GSM842758	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842758	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk352	pgxind-kftx63co	pgxcs-kftwojiy		PGX_AM_BS_GSM842741	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842741	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk35p	pgxind-kftx63dg	pgxcs-kftwojun		PGX_AM_BS_GSM842778	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842778	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk36k	pgxind-kftx63ej	pgxcs-kftwok0l		PGX_AM_BS_GSM842797	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842797	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk36p	pgxind-kftx63ep	pgxcs-kftwok1i		PGX_AM_BS_GSM842800	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842800	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk37d	pgxind-kftx63fj	pgxcs-kftwok64		PGX_AM_BS_GSM842815	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842815	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk37f	pgxind-kftx63fl	pgxcs-kftwok6f		PGX_AM_BS_GSM842816	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842816	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk37o	pgxind-kftx63fw	pgxcs-kftwok7z		PGX_AM_BS_GSM842821	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842821	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk37t	pgxind-kftx63g2	pgxcs-kftwok8x		PGX_AM_BS_GSM842824	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842824	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3gq	pgxind-kftx63qw	pgxcs-kftwolzy		PGX_AM_BS_GSM1018662	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018662	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3gy	pgxind-kftx63r6	pgxcs-kftwom1i		PGX_AM_BS_GSM1018667	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018667	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3h0	pgxind-kftx63r8	pgxcs-kftwom1u		PGX_AM_BS_GSM1018668	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018668	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3h8	pgxind-kftx63rj	pgxcs-kftwom3e		PGX_AM_BS_GSM1018673	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018673	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3hb	pgxind-kftx63rn	pgxcs-kftwom40		PGX_AM_BS_GSM1018675	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018675	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3hv	pgxind-kftx63sb	pgxcs-kftwom89		PGX_AM_BS_GSM1018688	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018688	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3id	pgxind-kftx63sx	pgxcs-kftwombq		PGX_AM_BS_GSM1018699	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018699	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3it	pgxind-kftx63ti	pgxcs-kftwomfe		PGX_AM_BS_GSM1018710	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018710	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3iv	pgxind-kftx63tk	pgxcs-kftwomfq		PGX_AM_BS_GSM1018711	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018711	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3k1	pgxind-kftx63v0	pgxcs-kftwomps		PGX_AM_BS_GSM1018741	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018741	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3ll	pgxind-kftx63wx	pgxcs-kftwom7f		PGX_AM_BS_GSM1018686	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018686	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3vg	pgxind-kftx6492	pgxcs-kftws1xm		PGX_AM_BS_GSM2036731	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036731	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3vq	pgxind-kftx649e	pgxcs-kftws20k		PGX_AM_BS_GSM2036737	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036737	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3wz	pgxind-kftx64ay	pgxcs-kftwop00		PGX_AM_BS_GSM2036765	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036765	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3xl	pgxind-kftx64bo	pgxcs-kftwop7x		PGX_AM_BS_GSM2036778	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036778	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3yy	pgxind-kftx64dd	pgxcs-kftwopjp		PGX_AM_BS_GSM2036808	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036808	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3zc	pgxind-kftx64dt	pgxcs-kftwopmu		PGX_AM_BS_GSM2036816	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036816	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3zd	pgxind-kftx64dw	pgxcs-kftwopn8		PGX_AM_BS_GSM2036817	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036817	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3zp	pgxind-kftx64ea	pgxcs-kftwoppz		PGX_AM_BS_GSM2036824	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036824	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3zs	pgxind-kftx64ee	pgxcs-kftwopqr		PGX_AM_BS_GSM2036826	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036826	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk41k	pgxind-kftx64gl	pgxcs-kftwoq66		PGX_AM_BS_GSM2036865	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036865	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk41u	pgxind-kftx64gy	pgxcs-kftwoq8j		PGX_AM_BS_GSM2036871	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036871	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk422	pgxind-kftx64h8	pgxcs-kftwoqaj		PGX_AM_BS_GSM2036876	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036876	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk432	pgxind-kftx64ig	pgxcs-kftwoqjd		PGX_AM_BS_GSM2036898	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036898	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk43w	pgxind-kftx64jg	pgxcs-kftwoqsw		PGX_AM_BS_GSM2036916	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036916	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk62r	pgxind-kftx66xi	pgxcs-kftwpad1		PGX_AM_BS_GSM482160	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482160	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk637	pgxind-kftx66y2	pgxcs-kftwpag7		PGX_AM_BS_GSM482170	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482170	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk64i	pgxind-kftx66zn	pgxcs-kftwpaoy		PGX_AM_BS_GSM482198	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482198	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk650	pgxind-kftx670a	pgxcs-kftwpasf		PGX_AM_BS_GSM482209	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482209	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkfkq	pgxind-kftx6ikp	pgxcs-kftwr742		PGX_AM_BS_GSM825045	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825045	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkft4	pgxind-kftx6iuz	pgxcs-kftwr9q0		PGX_AM_BS_GSM889595	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889595	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkft6	pgxind-kftx6iv1	pgxcs-kftwr9qi		PGX_AM_BS_GSM889601	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889601	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhdu	pgxind-kftx6ksy	pgxcs-kftwrnu3		PGX_AM_BS_GSM784290	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784290	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhe0	pgxind-kftx6kt6	pgxcs-kftwrnvd		PGX_AM_BS_GSM784294	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784294	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhgz	pgxind-kftx6kwu	pgxcs-kftwrofz		PGX_AM_BS_GSM784410	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784410	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhh0	pgxind-kftx6kww	pgxcs-kftwroga		PGX_AM_BS_GSM784411	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784411	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhig	pgxind-kftx6kyp	pgxcs-kftwroqb		PGX_AM_BS_GSM784443	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784443	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhii	pgxind-kftx6kyr	pgxcs-kftwroqm		PGX_AM_BS_GSM784444	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784444	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhil	pgxind-kftx6kyv	pgxcs-kftwrora		PGX_AM_BS_GSM784446	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784446	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhjg	pgxind-kftx6kzy	pgxcs-kftwrozf		PGX_AM_BS_GSM784465	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784465	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhjt	pgxind-kftx6l0e	pgxcs-kftwrp1z		PGX_AM_BS_GSM784473	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784473	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvks9q	pgxind-kftx6y0y	pgxcs-kftwtxfl		PGX_AM_BS_CELLLINE_CCLE_BROAD-ABC1_LUNG	Lung adenocarcinoma [cell line ABC-1]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				ABC-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksc9	pgxind-kftx6y44	pgxcs-kftwty9a		PGX_AM_BS_CELLLINE_CCLE_BROAD-CALU1_LUNG	Lung squamous cell carcinoma [cell line Calu-1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				Calu-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksi5	pgxind-kftx6ybi	pgxcs-kftwu036		PGX_AM_BS_CELLLINE_CCLE_BROAD-HARA_LUNG	Lung squamous cell carcinoma [cell line HARA [Human squamous cell lung carcinoma]]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				KCC-C1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksje	pgxind-kftx6yd1	pgxcs-kftwu0jc		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC78_LUNG	Lung adenocarcinoma [cell line HCC78]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC78								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksji	pgxind-kftx6yd5	pgxcs-kftwu0kb		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC95_LUNG	Lung squamous cell carcinoma [cell line HCC95]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC95								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksrp	pgxind-kftx6yng	pgxcs-kftwu368		PGX_AM_BS_CELLLINE_CCLE_BROAD-KNS62_LUNG	Lung squamous cell carcinoma [cell line KNS-62]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				KNS-62								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkst8	pgxind-kftx6ypb	pgxcs-kftwu3mi		PGX_AM_BS_CELLLINE_CCLE_BROAD-LC1F_LUNG	Lung squamous cell carcinoma [cell line LC-1F]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				LC-1F								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksu8	pgxind-kftx6yql	pgxcs-kftwu3zj		PGX_AM_BS_CELLLINE_CCLE_BROAD-LUDLU1_LUNG	Lung squamous cell carcinoma [cell line LUDLU-1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				LUDLU-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksxi	pgxind-kftx6yuq	pgxcs-kftwu4zd		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1105_LUNG	Lung small cell carcinoma [cell line NCI-H1105]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1105								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksxn	pgxind-kftx6yuw	pgxcs-kftwu530		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1299_LUNG	Lung large cell carcinoma [cell line NCI-H1299]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1299								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksy2	pgxind-kftx6yve	pgxcs-kftwu57m		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1437_LUNG	Lung adenocarcinoma [cell line NCI-H1437]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1437								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksy5	pgxind-kftx6yvi	pgxcs-kftwu58m		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1563_LUNG	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1563								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksy8	pgxind-kftx6yvn	pgxcs-kftwu59m		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1573_LUNG	Lung adenocarcinoma [cell line NCI-H1573]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1573								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyo	pgxind-kftx6yw7	pgxcs-kftwu5el		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1703_LUNG	Lung squamous cell carcinoma [cell line NCI-H1703]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1703								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyt	pgxind-kftx6ywd	pgxcs-kftwu5g4		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1781_LUNG	Minimally invasive lung adenocarcinoma [cell line NCI-H1781]	NCIT:C2923	Minimally invasive lung adenocarcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1781								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyw	pgxind-kftx6ywh	pgxcs-kftwu5h4		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1793_LUNG	Lung adenocarcinoma [cell line NCI-H1793]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1793								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt03	pgxind-kftx6yxx	pgxcs-kftwu5u0		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2126_LUNG	Lung large cell carcinoma [cell line NCI-H2126]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2126								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt0e	pgxind-kftx6yyc	pgxcs-kftwu5xh		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2228_LUNG	Lung adenocarcinoma [cell line NCI-H2228]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2228								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt0h	pgxind-kftx6yyg	pgxcs-kftwu5yf		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2286_LUNG	Lung squamous cell carcinoma [cell line NCI-H2286]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2286								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt0l	pgxind-kftx6yyk	pgxcs-kftwu5zg		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH23_LUNG	Lung adenocarcinoma [cell line NCI-H23]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H23								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1o	pgxind-kftx6yzx	pgxcs-kftwu6e0		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH661_LUNG	Lung large cell carcinoma [cell line NCI-H661]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H661								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1t	pgxind-kftx6z03	pgxcs-kftwu6fh		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH727_LUNG	Lung carcinoid tumor [cell line NCI-H727]	NCIT:C4038	Lung carcinoid tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H727								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt4t	pgxind-kftx6z3v	pgxcs-kftwu7ch		PGX_AM_BS_CELLLINE_CCLE_BROAD-PC14_LUNG	Lung adenocarcinoma [cell line PC-14]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				PC-14								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt68	pgxind-kftx6z5l	pgxcs-kftwu7u7		PGX_AM_BS_CELLLINE_CCLE_BROAD-RERFLCAI_LUNG	Lung squamous cell carcinoma [cell line RERF-LC-A1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				RERF-LC-A1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt8d	pgxind-kftx6z8c	pgxcs-kftwu8ho		PGX_AM_BS_CELLLINE_CCLE_BROAD-SKLU1_LUNG	Lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				SK-LU-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvktc2	pgxind-kftx6zd0	pgxcs-kftwu9o1		PGX_AM_BS_CELLLINE_CCLE_BROAD-SQ1_LUNG	Lung squamous cell carcinoma [cell line Sq-1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				Sq-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvktgh	pgxind-kftx6zij	pgxcs-kftwub4m		PGX_AM_BS_CELLLINE_CCLE_BROAD-VMRCLCP_LUNG	Lung squamous cell carcinoma [cell line VMRC-LCP]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				VMRC-LCP								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkths	pgxind-kftx6zk6	pgxcs-kftwubio		PGX_AM_BS_CELLLINE_NCI60-EKVX	Non-Small Cell Lung Cancer	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1				EKVX								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvktiv	pgxind-kftx6zlj	pgxcs-kftwubu7		PGX_AM_BS_CELLLINE_NCI60-NCI_H460	Non-Small Cell Lung Cancer	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1				NCI-H460								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv58	pgxind-kftx71oj	pgxcs-kftwuuie		PGX_AM_BS_LUNG_MSK_2017-P_0000163_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv5b	pgxind-kftx71on	pgxcs-kftwuuky		PGX_AM_BS_LUNG_MSK_2017-P_0000205_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv5f	pgxind-kftx71or	pgxcs-kftwuulx		PGX_AM_BS_LUNG_MSK_2017-P_0000208_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv63	pgxind-kftx71pl	pgxcs-kftwuut5		PGX_AM_BS_LUNG_MSK_2017-P_0000349_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv6e	pgxind-kftx71pz	pgxcs-kftwuuwh		PGX_AM_BS_LUNG_MSK_2017-P_0000427_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv6r	pgxind-kftx71qg	pgxcs-kftwuv0a		PGX_AM_BS_LUNG_MSK_2017-P_0000563_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv6z	pgxind-kftx71qq	pgxcs-kftwuv2p		PGX_AM_BS_LUNG_MSK_2017-P_0000594_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv7h	pgxind-kftx71rc	pgxcs-kftwuv7z		PGX_AM_BS_LUNG_MSK_2017-P_0000641_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv80	pgxind-kftx71s1	pgxcs-kftwuvdq		PGX_AM_BS_LUNG_MSK_2017-P_0000731_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv82	pgxind-kftx71s3	pgxcs-kftwuve8		PGX_AM_BS_LUNG_MSK_2017-P_0000732_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv87	pgxind-kftx71s9	pgxcs-kftwuvfo		PGX_AM_BS_LUNG_MSK_2017-P_0000774_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv8k	pgxind-kftx71sp	pgxcs-kftwuvji		PGX_AM_BS_LUNG_MSK_2017-P_0000831_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv8r	pgxind-kftx71sx	pgxcs-kftwuvlg		PGX_AM_BS_LUNG_MSK_2017-P_0000894_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv8v	pgxind-kftx71t3	pgxcs-kftwuvmv		PGX_AM_BS_LUNG_MSK_2017-P_0000913_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv95	pgxind-kftx71tf	pgxcs-kftwuvpr		PGX_AM_BS_LUNG_MSK_2017-P_0000987_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv9b	pgxind-kftx71tn	pgxcs-kftwuvtb		PGX_AM_BS_LUNG_MSK_2017-P_0001037_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv9l	pgxind-kftx71u0	pgxcs-kftwuvw7		PGX_AM_BS_LUNG_MSK_2017-P_0001123_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv9y	pgxind-kftx71ug	pgxcs-kftwuw02		PGX_AM_BS_LUNG_MSK_2017-P_0001189_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkva8	pgxind-kftx71us	pgxcs-kftwuw2y		PGX_AM_BS_LUNG_MSK_2017-P_0001243_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkva9	pgxind-kftx71uu	pgxcs-kftwuw3f		PGX_AM_BS_LUNG_MSK_2017-P_0001257_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvag	pgxind-kftx71v2	pgxcs-kftwuw5d		PGX_AM_BS_LUNG_MSK_2017-P_0001300_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvbc	pgxind-kftx71w7	pgxcs-kftwuwex		PGX_AM_BS_LUNG_MSK_2017-P_0001397_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvbu	pgxind-kftx71wu	pgxcs-kftwuwk7		PGX_AM_BS_LUNG_MSK_2017-P_0001576_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvcf	pgxind-kftx71xk	pgxcs-kftwuwqf		PGX_AM_BS_LUNG_MSK_2017-P_0001750_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvco	pgxind-kftx71xw	pgxcs-kftwuwtb		PGX_AM_BS_LUNG_MSK_2017-P_0001813_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvcq	pgxind-kftx71xy	pgxcs-kftwuwts		PGX_AM_BS_LUNG_MSK_2017-P_0001813_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvd4	pgxind-kftx71yh	pgxcs-kftwuwzs		PGX_AM_BS_LUNG_MSK_2017-P_0001840_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvdf	pgxind-kftx71yv	pgxcs-kftwux35		PGX_AM_BS_LUNG_MSK_2017-P_0001945_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvdh	pgxind-kftx71yx	pgxcs-kftwux3m		PGX_AM_BS_LUNG_MSK_2017-P_0001955_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkve8	pgxind-kftx71zv	pgxcs-kftwuxbt		PGX_AM_BS_LUNG_MSK_2017-P_0002081_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkven	pgxind-kftx720e	pgxcs-kftwuxg6		PGX_AM_BS_LUNG_MSK_2017-P_0002153_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkveq	pgxind-kftx720i	pgxcs-kftwuxh5		PGX_AM_BS_LUNG_MSK_2017-P_0002160_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvgt	pgxind-kftx7234	pgxcs-kftwuy37		PGX_AM_BS_LUNG_MSK_2017-P_0002635_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvgv	pgxind-kftx7236	pgxcs-kftwuy3p		PGX_AM_BS_LUNG_MSK_2017-P_0002639_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvh6	pgxind-kftx723k	pgxcs-kftwuy8m		PGX_AM_BS_LUNG_MSK_2017-P_0002707_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvhz	pgxind-kftx724l	pgxcs-kftwuyh8		PGX_AM_BS_LUNG_MSK_2017-P_0002850_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvic	pgxind-kftx7251	pgxcs-kftwuyl3		PGX_AM_BS_LUNG_MSK_2017-P_0002890_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvin	pgxind-kftx725f	pgxcs-kftwuyog		PGX_AM_BS_LUNG_MSK_2017-P_0002917_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvjc	pgxind-kftx7269	pgxcs-kftwuyvm		PGX_AM_BS_LUNG_MSK_2017-P_0003070_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvjq	pgxind-kftx726r	pgxcs-kftwuz00		PGX_AM_BS_LUNG_MSK_2017-P_0003169_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvju	pgxind-kftx726v	pgxcs-kftwuz0y		PGX_AM_BS_LUNG_MSK_2017-P_0003201_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvjx	pgxind-kftx726z	pgxcs-kftwuz1w		PGX_AM_BS_LUNG_MSK_2017-P_0003206_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvka	pgxind-kftx727f	pgxcs-kftwuz5q		PGX_AM_BS_LUNG_MSK_2017-P_0003250_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvl7	pgxind-kftx728j	pgxcs-kftwuzgu		PGX_AM_BS_LUNG_MSK_2017-P_0003460_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvlw	pgxind-kftx729g	pgxcs-kftwuzoj		PGX_AM_BS_LUNG_MSK_2017-P_0003586_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvnd	pgxind-kftx72ba	pgxcs-kftwv04e		PGX_AM_BS_LUNG_MSK_2017-P_0003970_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvns	pgxind-kftx72bt	pgxcs-kftwv08s		PGX_AM_BS_LUNG_MSK_2017-P_0004087_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvnu	pgxind-kftx72bv	pgxcs-kftwv09a		PGX_AM_BS_LUNG_MSK_2017-P_0004099_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvnz	pgxind-kftx72c1	pgxcs-kftwv0aq		PGX_AM_BS_LUNG_MSK_2017-P_0004110_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvov	pgxind-kftx72d6	pgxcs-kftwv0m1		PGX_AM_BS_LUNG_MSK_2017-P_0004315_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvqd	pgxind-kftx72f1	pgxcs-kftwv11w		PGX_AM_BS_LUNG_MSK_2017-P_0004615_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvqe	pgxind-kftx72f3	pgxcs-kftwv12d		PGX_AM_BS_LUNG_MSK_2017-P_0004643_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvsd	pgxind-kftx72hl	pgxcs-kftwv1nf		PGX_AM_BS_LUNG_MSK_2017-P_0005170_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvte	pgxind-kftx72it	pgxcs-kftwv1zg		PGX_AM_BS_LUNG_MSK_2017-P_0005464_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvth	pgxind-kftx72ix	pgxcs-kftwv20f		PGX_AM_BS_LUNG_MSK_2017-P_0005476_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvtk	pgxind-kftx72j1	pgxcs-kftwv21e		PGX_AM_BS_LUNG_MSK_2017-P_0005504_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvts	pgxind-kftx72jb	pgxcs-kftwv23s		PGX_AM_BS_LUNG_MSK_2017-P_0005553_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvuk	pgxind-kftx72ka	pgxcs-kftwv2bx		PGX_AM_BS_LUNG_MSK_2017-P_0005868_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvvt	pgxind-kftx72lv	pgxcs-kftwv2pa		PGX_AM_BS_LUNG_MSK_2017-P_0006149_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvw0	pgxind-kftx72m3	pgxcs-kftwv2r8		PGX_AM_BS_LUNG_MSK_2017-P_0006198_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvw8	pgxind-kftx72md	pgxcs-kftwv2tn		PGX_AM_BS_LUNG_MSK_2017-P_0006221_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvwj	pgxind-kftx72mr	pgxcs-kftwv2wy		PGX_AM_BS_LUNG_MSK_2017-P_0006312_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvxo	pgxind-kftx72o6	pgxcs-kftwv3ai		PGX_AM_BS_LUNG_MSK_2017-P_0006671_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvxt	pgxind-kftx72oc	pgxcs-kftwv3by		PGX_AM_BS_LUNG_MSK_2017-P_0006718_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvy2	pgxind-kftx72oo	pgxcs-kftwv3eu		PGX_AM_BS_LUNG_MSK_2017-P_0006789_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvyk	pgxind-kftx72pb	pgxcs-kftwv3k5		PGX_AM_BS_LUNG_MSK_2017-P_0006913_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvyn	pgxind-kftx72pf	pgxcs-kftwv3l3		PGX_AM_BS_LUNG_MSK_2017-P_0006921_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvz5	pgxind-kftx72q1	pgxcs-kftwv3qc		PGX_AM_BS_LUNG_MSK_2017-P_0007044_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzh	pgxind-kftx72qh	pgxcs-kftwv3u7		PGX_AM_BS_LUNG_MSK_2017-P_0007101_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzu	pgxind-kftx72qy	pgxcs-kftwv3y0		PGX_AM_BS_LUNG_MSK_2017-P_0007167_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw0m	pgxind-kftx72rw	pgxcs-kftwv47r		PGX_AM_BS_LUNG_MSK_2017-P_0007420_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw0q	pgxind-kftx72s2	pgxcs-kftwv497		PGX_AM_BS_LUNG_MSK_2017-P_0007491_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw1a	pgxind-kftx72sr	pgxcs-kftwv4f0		PGX_AM_BS_LUNG_MSK_2017-P_0007597_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw1f	pgxind-kftx72sx	pgxcs-kftwv4gg		PGX_AM_BS_LUNG_MSK_2017-P_0007643_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw1p	pgxind-kftx72t9	pgxcs-kftwv4jc		PGX_AM_BS_LUNG_MSK_2017-P_0007754_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw1q	pgxind-kftx72tb	pgxcs-kftwv4ju		PGX_AM_BS_LUNG_MSK_2017-P_0007775_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw22	pgxind-kftx72tp	pgxcs-kftwv4n8		PGX_AM_BS_LUNG_MSK_2017-P_0007870_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw26	pgxind-kftx72tw	pgxcs-kftwv4op		PGX_AM_BS_LUNG_MSK_2017-P_0007911_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw28	pgxind-kftx72ty	pgxcs-kftwv4p6		PGX_AM_BS_LUNG_MSK_2017-P_0007916_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw2l	pgxind-kftx72ue	pgxcs-kftwv4t1		PGX_AM_BS_LUNG_MSK_2017-P_0008134_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw2r	pgxind-kftx72un	pgxcs-kftwv4uy		PGX_AM_BS_LUNG_MSK_2017-P_0008161_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw2w	pgxind-kftx72ut	pgxcs-kftwv4we		PGX_AM_BS_LUNG_MSK_2017-P_0008261_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw3n	pgxind-kftx72vq	pgxcs-kftwv547		PGX_AM_BS_LUNG_MSK_2017-P_0008426_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw42	pgxind-kftx72w9	pgxcs-kftwv58i		PGX_AM_BS_LUNG_MSK_2017-P_0008487_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw4a	pgxind-kftx72wi	pgxcs-kftwv5aw		PGX_AM_BS_LUNG_MSK_2017-P_0008602_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw4q	pgxind-kftx72x3	pgxcs-kftwv5ha		PGX_AM_BS_LUNG_MSK_2017-P_0008764_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw51	pgxind-kftx72xh	pgxcs-kftwv5kn		PGX_AM_BS_LUNG_MSK_2017-P_0008855_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw5j	pgxind-kftx72y4	pgxcs-kftwv5px		PGX_AM_BS_LUNG_MSK_2017-P_0008934_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw66	pgxind-kftx72yx	pgxcs-kftwv5wo		PGX_AM_BS_LUNG_MSK_2017-P_0009171_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw68	pgxind-kftx72yz	pgxcs-kftwv5x5		PGX_AM_BS_LUNG_MSK_2017-P_0009172_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw6y	pgxind-kftx72zv	pgxcs-kftwv64s		PGX_AM_BS_LUNG_MSK_2017-P_0009293_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw75	pgxind-kftx7305	pgxcs-kftwv676		PGX_AM_BS_LUNG_MSK_2017-P_0009346_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw7k	pgxind-kftx730n	pgxcs-kftwv6bh		PGX_AM_BS_LUNG_MSK_2017-P_0009428_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw80	pgxind-kftx7318	pgxcs-kftwv6gb		PGX_AM_BS_LUNG_MSK_2017-P_0009505_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw82	pgxind-kftx731a	pgxcs-kftwv6gs		PGX_AM_BS_LUNG_MSK_2017-P_0009508_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw8f	pgxind-kftx731q	pgxcs-kftwv6ma		PGX_AM_BS_LUNG_MSK_2017-P_0009559_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw8g	pgxind-kftx731s	pgxcs-kftwv6mt		PGX_AM_BS_LUNG_MSK_2017-P_0009586_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw8k	pgxind-kftx731w	pgxcs-kftwv6ns		PGX_AM_BS_LUNG_MSK_2017-P_0009604_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw8u	pgxind-kftx7328	pgxcs-kftwv6qp		PGX_AM_BS_LUNG_MSK_2017-P_0009660_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw9w	pgxind-kftx733j	pgxcs-kftwv71o		PGX_AM_BS_LUNG_MSK_2017-P_0009959_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwan	pgxind-kftx734f	pgxcs-kftwv79g		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX206B	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwaq	pgxind-kftx734j	pgxcs-kftwv7af		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX212	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbo	pgxind-kftx735q	pgxcs-kftwv7kl		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX304	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbw	pgxind-kftx7361	pgxcs-kftwv7n1		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX323	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwc5	pgxind-kftx736d	pgxcs-kftwv7py		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX370	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwco	pgxind-kftx7372	pgxcs-kftwv7xn		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX479	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwd7	pgxind-kftx737q	pgxcs-kftwv83h		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX59	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwdj	pgxind-kftx7385	pgxcs-kftwv86z		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX68	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwds	pgxind-kftx738h	pgxcs-kftwv8a2		PGX_AM_BS_LUNG_MSK_PDX-P_0000636_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwey	pgxind-kftx739z	pgxcs-kftwv8mp		PGX_AM_BS_LUNG_MSK_PDX-P_0009358_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwf6	pgxind-kftx73a9	pgxcs-kftwv8p5		PGX_AM_BS_LUNG_MSK_PDX-P_0010901_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfm	pgxind-kftx73at	pgxcs-kftwv8u0		PGX_AM_BS_LUNG_MSK_PDX-P_0012443_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfo	pgxind-kftx73av	pgxcs-kftwv8ui		PGX_AM_BS_LUNG_MSK_PDX-P_0012736_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfv	pgxind-kftx73b3	pgxcs-kftwv8wf		PGX_AM_BS_LUNG_MSK_PDX-P_0014389_T01_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfy	pgxind-kftx73b8	pgxcs-kftwv8xd		PGX_AM_BS_LUNG_MSK_PDX-P_0015360_T02_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwnb	pgxind-kftx73kg	pgxcs-kftwvb8u		PGX_AM_BS_MSK_IMPACT_2017-P_0000163_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwnd	pgxind-kftx73ki	pgxcs-kftwvb9b		PGX_AM_BS_MSK_IMPACT_2017-P_0000165_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwou	pgxind-kftx73me	pgxcs-kftwvbrb		PGX_AM_BS_MSK_IMPACT_2017-P_0000205_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwoz	pgxind-kftx73mk	pgxcs-kftwvbsq		PGX_AM_BS_MSK_IMPACT_2017-P_0000208_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwp1	pgxind-kftx73mm	pgxcs-kftwvbt7		PGX_AM_BS_MSK_IMPACT_2017-P_0000208_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwqa	pgxind-kftx73o7	pgxcs-kftwvc6n		PGX_AM_BS_MSK_IMPACT_2017-P_0000235_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwtf	pgxind-kftx73s3	pgxcs-kftwvd5o		PGX_AM_BS_MSK_IMPACT_2017-P_0000315_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwvm	pgxind-kftx73uu	pgxcs-kftwvdt8		PGX_AM_BS_MSK_IMPACT_2017-P_0000363_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx0b	pgxind-kftx740s	pgxcs-kftwvfbk		PGX_AM_BS_MSK_IMPACT_2017-P_0000463_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx4j	pgxind-kftx7460	pgxcs-kftwvglw		PGX_AM_BS_MSK_IMPACT_2017-P_0000563_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx7a	pgxind-kftx749h	pgxcs-kftwvhh0		PGX_AM_BS_MSK_IMPACT_2017-P_0000626_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx9i	pgxind-kftx74c8	pgxcs-kftwvi6l		PGX_AM_BS_MSK_IMPACT_2017-P_0000671_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxc4	pgxind-kftx74fi	pgxcs-kftwvj0g		PGX_AM_BS_MSK_IMPACT_2017-P_0000726_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxe4	pgxind-kftx74i2	pgxcs-kftwvjm3		PGX_AM_BS_MSK_IMPACT_2017-P_0000774_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxek	pgxind-kftx74in	pgxcs-kftwvjqw		PGX_AM_BS_MSK_IMPACT_2017-P_0000785_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxgv	pgxind-kftx74lk	pgxcs-kftwvkhx		PGX_AM_BS_MSK_IMPACT_2017-P_0000840_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxic	pgxind-kftx74nf	pgxcs-kftwvkxo		PGX_AM_BS_MSK_IMPACT_2017-P_0000873_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxn8	pgxind-kftx74tm	pgxcs-kftwvmi9		PGX_AM_BS_MSK_IMPACT_2017-P_0000978_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxt9	pgxind-kftx7514	pgxcs-kftwvoc9		PGX_AM_BS_MSK_IMPACT_2017-P_0001117_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxtg	pgxind-kftx751c	pgxcs-kftwvoe8		PGX_AM_BS_MSK_IMPACT_2017-P_0001123_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxth	pgxind-kftx751e	pgxcs-kftwvoeq		PGX_AM_BS_MSK_IMPACT_2017-P_0001123_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxuj	pgxind-kftx752p	pgxcs-kftwvopw		PGX_AM_BS_MSK_IMPACT_2017-P_0001155_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxuu	pgxind-kftx7534	pgxcs-kftwvot8		PGX_AM_BS_MSK_IMPACT_2017-P_0001165_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxxk	pgxind-kftx756i	pgxcs-kftwvpob		PGX_AM_BS_MSK_IMPACT_2017-P_0001224_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxyg	pgxind-kftx757n	pgxcs-kftwvpxz		PGX_AM_BS_MSK_IMPACT_2017-P_0001241_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxz1	pgxind-kftx758e	pgxcs-kftwvq6b		PGX_AM_BS_MSK_IMPACT_2017-P_0001257_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxzt	pgxind-kftx759d	pgxcs-kftwvqeh		PGX_AM_BS_MSK_IMPACT_2017-P_0001278_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky0q	pgxind-kftx75ak	pgxcs-kftwvqoj		PGX_AM_BS_MSK_IMPACT_2017-P_0001300_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky0s	pgxind-kftx75am	pgxcs-kftwvqp0		PGX_AM_BS_MSK_IMPACT_2017-P_0001300_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky0z	pgxind-kftx75au	pgxcs-kftwvqqy		PGX_AM_BS_MSK_IMPACT_2017-P_0001303_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky13	pgxind-kftx75b0	pgxcs-kftwvqse		PGX_AM_BS_MSK_IMPACT_2017-P_0001305_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky1h	pgxind-kftx75be	pgxcs-kftwvqw8		PGX_AM_BS_MSK_IMPACT_2017-P_0001314_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky3t	pgxind-kftx75eb	pgxcs-kftwvrnh		PGX_AM_BS_MSK_IMPACT_2017-P_0001365_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky55	pgxind-kftx75g0	pgxcs-kftwvs1u		PGX_AM_BS_MSK_IMPACT_2017-P_0001397_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky7b	pgxind-kftx75iq	pgxcs-kftwvsr5		PGX_AM_BS_MSK_IMPACT_2017-P_0001442_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkymh	pgxind-kftx761x	pgxcs-kftwvxja		PGX_AM_BS_MSK_IMPACT_2017-P_0001782_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyms	pgxind-kftx762b	pgxcs-kftwvxmp		PGX_AM_BS_MSK_IMPACT_2017-P_0001790_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyrw	pgxind-kftx768m	pgxcs-kftwvz6k		PGX_AM_BS_MSK_IMPACT_2017-P_0001894_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkys2	pgxind-kftx768u	pgxcs-kftwvz8i		PGX_AM_BS_MSK_IMPACT_2017-P_0001898_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyss	pgxind-kftx769q	pgxcs-kftwvzg6		PGX_AM_BS_MSK_IMPACT_2017-P_0001916_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz00	pgxind-kftx76ir	pgxcs-kftww1oo		PGX_AM_BS_MSK_IMPACT_2017-P_0002081_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz08	pgxind-kftx76j1	pgxcs-kftww1r2		PGX_AM_BS_MSK_IMPACT_2017-P_0002085_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz14	pgxind-kftx76k4	pgxcs-kftww205		PGX_AM_BS_MSK_IMPACT_2017-P_0002105_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz5u	pgxind-kftx76py	pgxcs-kftww3hr		PGX_AM_BS_MSK_IMPACT_2017-P_0002207_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzfz	pgxind-kftx772j	pgxcs-kftww6lr		PGX_AM_BS_MSK_IMPACT_2017-P_0002426_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzgt	pgxind-kftx773k	pgxcs-kftww6uf		PGX_AM_BS_MSK_IMPACT_2017-P_0002446_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzh3	pgxind-kftx773w	pgxcs-kftww6xd		PGX_AM_BS_MSK_IMPACT_2017-P_0002451_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkziv	pgxind-kftx7763	pgxcs-kftww7ia		PGX_AM_BS_MSK_IMPACT_2017-P_0002489_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzp7	pgxind-kftx77e1	pgxcs-kftww9fq		PGX_AM_BS_MSK_IMPACT_2017-P_0002637_T01_IM3	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzpw	pgxind-kftx77ev	pgxcs-kftww9pc		PGX_AM_BS_MSK_IMPACT_2017-P_0002651_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzs8	pgxind-kftx77hr	pgxcs-kftwwadt		PGX_AM_BS_MSK_IMPACT_2017-P_0002707_T03_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzuj	pgxind-kftx77kp	pgxcs-kftwwb4w		PGX_AM_BS_MSK_IMPACT_2017-P_0002759_T01_IM3	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzvj	pgxind-kftx77lx	pgxcs-kftwwbfg		PGX_AM_BS_MSK_IMPACT_2017-P_0002783_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzwm	pgxind-kftx77na	pgxcs-kftwwbqz		PGX_AM_BS_MSK_IMPACT_2017-P_0002808_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzzi	pgxind-kftx77qz	pgxcs-kftwwcox		PGX_AM_BS_MSK_IMPACT_2017-P_0002872_T01_IM3	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl05u	pgxind-kftx77yx	pgxcs-kftwwepl		PGX_AM_BS_MSK_IMPACT_2017-P_0003013_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl060	pgxind-kftx77z5	pgxcs-kftwwerj		PGX_AM_BS_MSK_IMPACT_2017-P_0003017_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl06u	pgxind-kftx7808	pgxcs-kftwwf0p		PGX_AM_BS_MSK_IMPACT_2017-P_0003034_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0aa	pgxind-kftx784m	pgxcs-kftwwg3v		PGX_AM_BS_MSK_IMPACT_2017-P_0003125_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0dq	pgxind-kftx788w	pgxcs-kftwwh6y		PGX_AM_BS_MSK_IMPACT_2017-P_0003201_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0fi	pgxind-kftx78b4	pgxcs-kftwwhpp		PGX_AM_BS_MSK_IMPACT_2017-P_0003240_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0hf	pgxind-kftx78dj	pgxcs-kftwwicm		PGX_AM_BS_MSK_IMPACT_2017-P_0003282_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0rv	pgxind-kftx78qk	pgxcs-kftwwlj6		PGX_AM_BS_MSK_IMPACT_2017-P_0003527_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0uo	pgxind-kftx78u3	pgxcs-kftwwmfd		PGX_AM_BS_MSK_IMPACT_2017-P_0003584_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl10j	pgxind-kftx791l	pgxcs-kftwwoaz		PGX_AM_BS_MSK_IMPACT_2017-P_0003714_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl11c	pgxind-kftx792m	pgxcs-kftwwojp		PGX_AM_BS_MSK_IMPACT_2017-P_0003732_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl13b	pgxind-kftx7953	pgxcs-kftwwp4v		PGX_AM_BS_MSK_IMPACT_2017-P_0003773_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl19e	pgxind-kftx79cm	pgxcs-kftwwr1q		PGX_AM_BS_MSK_IMPACT_2017-P_0003913_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1f2	pgxind-kftx79je	pgxcs-kftwwsrn		PGX_AM_BS_MSK_IMPACT_2017-P_0004054_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1hk	pgxind-kftx79mj	pgxcs-kftwwtkq		PGX_AM_BS_MSK_IMPACT_2017-P_0004110_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1jl	pgxind-kftx79p2	pgxcs-kftwwu6c		PGX_AM_BS_MSK_IMPACT_2017-P_0004152_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1p7	pgxind-kftx79w6	pgxcs-kftwwvzc		PGX_AM_BS_MSK_IMPACT_2017-P_0004271_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1pf	pgxind-kftx79wh	pgxcs-kftwww1s		PGX_AM_BS_MSK_IMPACT_2017-P_0004276_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1rn	pgxind-kftx79z7	pgxcs-kftwwwpe		PGX_AM_BS_MSK_IMPACT_2017-P_0004328_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1t4	pgxind-kftx7a13	pgxcs-kftwwx7k		PGX_AM_BS_MSK_IMPACT_2017-P_0004361_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1ut	pgxind-kftx7a36	pgxcs-kftwwxpg		PGX_AM_BS_MSK_IMPACT_2017-P_0004395_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1wn	pgxind-kftx7a5i	pgxcs-kftwwybj		PGX_AM_BS_MSK_IMPACT_2017-P_0004436_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1xr	pgxind-kftx7a6x	pgxcs-kftwwyno		PGX_AM_BS_MSK_IMPACT_2017-P_0004463_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1yh	pgxind-kftx7a7u	pgxcs-kftwwyvg		PGX_AM_BS_MSK_IMPACT_2017-P_0004488_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1yt	pgxind-kftx7a88	pgxcs-kftwwyyt		PGX_AM_BS_MSK_IMPACT_2017-P_0004496_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl22u	pgxind-kftx7add	pgxcs-kftwx08d		PGX_AM_BS_MSK_IMPACT_2017-P_0004591_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl271	pgxind-kftx7ain	pgxcs-kftwx1jd		PGX_AM_BS_MSK_IMPACT_2017-P_0004678_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl28n	pgxind-kftx7akp	pgxcs-kftwx22p		PGX_AM_BS_MSK_IMPACT_2017-P_0004710_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2fa	pgxind-kftx7at3	pgxcs-kftwx43u		PGX_AM_BS_MSK_IMPACT_2017-P_0004858_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2r5	pgxind-kftx7b81	pgxcs-kftwx7vb		PGX_AM_BS_MSK_IMPACT_2017-P_0005123_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3af	pgxind-kftx7bw1	pgxcs-kftwxgf1		PGX_AM_BS_MSK_IMPACT_2017-P_0005562_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3b8	pgxind-kftx7bx1	pgxcs-kftwxgw9		PGX_AM_BS_MSK_IMPACT_2017-P_0005580_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3gj	pgxind-kftx7c3q	pgxcs-kftwxka7		PGX_AM_BS_MSK_IMPACT_2017-P_0005707_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3i9	pgxind-kftx7c5y	pgxcs-kftwxld0		PGX_AM_BS_MSK_IMPACT_2017-P_0005743_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3j6	pgxind-kftx7c75	pgxcs-kftwxlxb		PGX_AM_BS_MSK_IMPACT_2017-P_0005763_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3nu	pgxind-kftx7ccw	pgxcs-kftwxorp		PGX_AM_BS_MSK_IMPACT_2017-P_0005868_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3p3	pgxind-kftx7ceg	pgxcs-kftwxpk6		PGX_AM_BS_MSK_IMPACT_2017-P_0005897_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3pe	pgxind-kftx7ceu	pgxcs-kftwxpqx		PGX_AM_BS_MSK_IMPACT_2017-P_0005903_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3qm	pgxind-kftx7cgd	pgxcs-kftwxqjc		PGX_AM_BS_MSK_IMPACT_2017-P_0005931_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3sq	pgxind-kftx7cj2	pgxcs-kftwxrv5		PGX_AM_BS_MSK_IMPACT_2017-P_0005975_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3t3	pgxind-kftx7cjj	pgxcs-kftwxs2w		PGX_AM_BS_MSK_IMPACT_2017-P_0005985_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3wk	pgxind-kftx7cnw	pgxcs-kftwxu8k		PGX_AM_BS_MSK_IMPACT_2017-P_0006065_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl409	pgxind-kftx7csj	pgxcs-kftwxwjq		PGX_AM_BS_MSK_IMPACT_2017-P_0006149_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl40d	pgxind-kftx7csn	pgxcs-kftwxwlo		PGX_AM_BS_MSK_IMPACT_2017-P_0006151_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl42c	pgxind-kftx7cv2	pgxcs-kftwxxtp		PGX_AM_BS_MSK_IMPACT_2017-P_0006195_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl42k	pgxind-kftx7cvc	pgxcs-kftwxxyi		PGX_AM_BS_MSK_IMPACT_2017-P_0006199_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4gt	pgxind-kftx7dd2	pgxcs-kftwy6qx		PGX_AM_BS_MSK_IMPACT_2017-P_0006511_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4mn	pgxind-kftx7dkc	pgxcs-kftwyadf		PGX_AM_BS_MSK_IMPACT_2017-P_0006640_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4px	pgxind-kftx7doh	pgxcs-kftwycgn		PGX_AM_BS_MSK_IMPACT_2017-P_0006713_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4q7	pgxind-kftx7dot	pgxcs-kftwycmi		PGX_AM_BS_MSK_IMPACT_2017-P_0006718_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4qh	pgxind-kftx7dp5	pgxcs-kftwycse		PGX_AM_BS_MSK_IMPACT_2017-P_0006724_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4rh	pgxind-kftx7dqe	pgxcs-kftwydd4		PGX_AM_BS_MSK_IMPACT_2017-P_0006747_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4sf	pgxind-kftx7drk	pgxcs-kftwydzo		PGX_AM_BS_MSK_IMPACT_2017-P_0006768_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4sp	pgxind-kftx7drv	pgxcs-kftwye5i		PGX_AM_BS_MSK_IMPACT_2017-P_0006775_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4sv	pgxind-kftx7ds3	pgxcs-kftwye9b		PGX_AM_BS_MSK_IMPACT_2017-P_0006779_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4tm	pgxind-kftx7dsz	pgxcs-kftwyer6		PGX_AM_BS_MSK_IMPACT_2017-P_0006793_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4ud	pgxind-kftx7dtx	pgxcs-kftwyf7o		PGX_AM_BS_MSK_IMPACT_2017-P_0006810_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4xf	pgxind-kftx7dxr	pgxcs-kftwyh5d		PGX_AM_BS_MSK_IMPACT_2017-P_0006878_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4y8	pgxind-kftx7dys	pgxcs-kftwyhmo		PGX_AM_BS_MSK_IMPACT_2017-P_0006896_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4z2	pgxind-kftx7dzt	pgxcs-kftwyi3x		PGX_AM_BS_MSK_IMPACT_2017-P_0006914_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4zd	pgxind-kftx7e07	pgxcs-kftwyid3		PGX_AM_BS_MSK_IMPACT_2017-P_0006921_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl50b	pgxind-kftx7e1e	pgxcs-kftwyixb		PGX_AM_BS_MSK_IMPACT_2017-P_0006941_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl50m	pgxind-kftx7e1s	pgxcs-kftwyj40		PGX_AM_BS_MSK_IMPACT_2017-P_0006950_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl51s	pgxind-kftx7e39	pgxcs-kftwyjvd		PGX_AM_BS_MSK_IMPACT_2017-P_0006979_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl54l	pgxind-kftx7e6t	pgxcs-kftwyln7		PGX_AM_BS_MSK_IMPACT_2017-P_0007044_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl55z	pgxind-kftx7e8j	pgxcs-kftwymiq		PGX_AM_BS_MSK_IMPACT_2017-P_0007074_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl575	pgxind-kftx7ea1	pgxcs-kftwynac		PGX_AM_BS_MSK_IMPACT_2017-P_0007101_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl57q	pgxind-kftx7ear	pgxcs-kftwynmw		PGX_AM_BS_MSK_IMPACT_2017-P_0007114_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl58j	pgxind-kftx7ebs	pgxcs-kftwyo4d		PGX_AM_BS_MSK_IMPACT_2017-P_0007131_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5a8	pgxind-kftx7edy	pgxcs-kftwyp5w		PGX_AM_BS_MSK_IMPACT_2017-P_0007167_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5co	pgxind-kftx7eh0	pgxcs-kftwyqom		PGX_AM_BS_MSK_IMPACT_2017-P_0007236_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5ff	pgxind-kftx7ekg	pgxcs-kftwysg0		PGX_AM_BS_MSK_IMPACT_2017-P_0007318_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5jv	pgxind-kftx7eq2	pgxcs-kftwyv8h		PGX_AM_BS_MSK_IMPACT_2017-P_0007418_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5lt	pgxind-kftx7esi	pgxcs-kftwywgv		PGX_AM_BS_MSK_IMPACT_2017-P_0007513_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5ou	pgxind-kftx7ewd	pgxcs-kftwyyfm		PGX_AM_BS_MSK_IMPACT_2017-P_0007582_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5ov	pgxind-kftx7ewf	pgxcs-kftwyygm		PGX_AM_BS_MSK_IMPACT_2017-P_0007583_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5pi	pgxind-kftx7ex7	pgxcs-kftwyyu8		PGX_AM_BS_MSK_IMPACT_2017-P_0007597_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5qt	pgxind-kftx7eyu	pgxcs-kftwyzom		PGX_AM_BS_MSK_IMPACT_2017-P_0007638_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5sq	pgxind-kftx7f19	pgxcs-kftwz0wq		PGX_AM_BS_MSK_IMPACT_2017-P_0007681_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5v9	pgxind-kftx7f4h	pgxcs-kftwz2gs		PGX_AM_BS_MSK_IMPACT_2017-P_0007775_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5va	pgxind-kftx7f4j	pgxcs-kftwz2hq		PGX_AM_BS_MSK_IMPACT_2017-P_0007776_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5vv	pgxind-kftx7f5a	pgxcs-kftwz2ud		PGX_AM_BS_MSK_IMPACT_2017-P_0007788_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5yw	pgxind-kftx7f96	pgxcs-kftwz4ry		PGX_AM_BS_MSK_IMPACT_2017-P_0007879_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl60x	pgxind-kftx7fc0	pgxcs-kftwz62s		PGX_AM_BS_MSK_IMPACT_2017-P_0007924_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl684	pgxind-kftx7fl3	pgxcs-kftwzakz		PGX_AM_BS_MSK_IMPACT_2017-P_0008134_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6h6	pgxind-kftx7fwl	pgxcs-kftwzgcy		PGX_AM_BS_MSK_IMPACT_2017-P_0008378_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6id	pgxind-kftx7fy4	pgxcs-kftwzh5k		PGX_AM_BS_MSK_IMPACT_2017-P_0008404_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6m2	pgxind-kftx7g2s	pgxcs-kftwzjhl		PGX_AM_BS_MSK_IMPACT_2017-P_0008514_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6td	pgxind-kftx7gby	pgxcs-kftwzo0g		PGX_AM_BS_MSK_IMPACT_2017-P_0008715_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6vb	pgxind-kftx7gee	pgxcs-kftwzp8r		PGX_AM_BS_MSK_IMPACT_2017-P_0008764_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7eg	pgxind-kftx7h2a	pgxcs-kftx01ci		PGX_AM_BS_MSK_IMPACT_2017-P_0009289_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7ez	pgxind-kftx7h2z	pgxcs-kftx01o3		PGX_AM_BS_MSK_IMPACT_2017-P_0009301_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7h8	pgxind-kftx7h5t	pgxcs-kftx032s		PGX_AM_BS_MSK_IMPACT_2017-P_0009353_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7k6	pgxind-kftx7has	pgxcs-kftx04yn		PGX_AM_BS_MSK_IMPACT_2017-P_0009434_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7nt	pgxind-kftx7hf8	pgxcs-kftx079y		PGX_AM_BS_MSK_IMPACT_2017-P_0009526_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7sr	pgxind-kftx7hla	pgxcs-kftx0aci		PGX_AM_BS_MSK_IMPACT_2017-P_0009660_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7t4	pgxind-kftx7hlr	pgxcs-kftx0amo		PGX_AM_BS_MSK_IMPACT_2017-P_0009684_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7u0	pgxind-kftx7hmu	pgxcs-kftx0b63		PGX_AM_BS_MSK_IMPACT_2017-P_0009704_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7u7	pgxind-kftx7hn2	pgxcs-kftx0b9w		PGX_AM_BS_MSK_IMPACT_2017-P_0009708_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8a9	pgxind-kftx7i78	pgxcs-kftx0hpm		PGX_AM_BS_MSK_IMPACT_2017-P_0010131_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8ii	pgxind-kftx7ihq	pgxcs-kftx0kby		PGX_AM_BS_MSK_IMPACT_2017-P_0010355_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8lu	pgxind-kftx7ilz	pgxcs-kftx0lcc		PGX_AM_BS_MSK_IMPACT_2017-P_0010466_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8rj	pgxind-kftx7iq9	pgxcs-kftx0mes		PGX_AM_BS_MSK_IMPACT_2017-P_0010571_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8t5	pgxind-kftx7isb	pgxcs-kftx0myd		PGX_AM_BS_MSK_IMPACT_2017-P_0010610_T01_IM5	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8tu	pgxind-kftx7it5	pgxcs-kftx0n5l		PGX_AM_BS_MSK_IMPACT_2017-P_0010636_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8w6	pgxind-kftx7iw4	pgxcs-kftx0nuj		PGX_AM_BS_MSK_IMPACT_2017-P_0010688_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8zz	pgxind-kftx7j0z	pgxcs-kftx0p1n		PGX_AM_BS_MSK_IMPACT_2017-P_0010793_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl93m	pgxind-kftx7j5k	pgxcs-kftx0q74		PGX_AM_BS_MSK_IMPACT_2017-P_0010892_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl93s	pgxind-kftx7j5s	pgxcs-kftx0q93		PGX_AM_BS_MSK_IMPACT_2017-P_0010896_T01_IM5	Lung Neuroendocrine Tumor	NCIT:C5670	Lung Neuroendocrine Neoplasm	pgx:icdom-82463	Neuroendocrine carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl97y	pgxind-kftx7jb0	pgxcs-kftx0rmw		PGX_AM_BS_MSK_IMPACT_2017-P_0010995_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl991	pgxind-kftx7jcd	pgxcs-kftx0ryp		PGX_AM_BS_MSK_IMPACT_2017-P_0011025_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl99c	pgxind-kftx7jcr	pgxcs-kftx0s25		PGX_AM_BS_MSK_IMPACT_2017-P_0011031_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9cc	pgxind-kftx7jgk	pgxcs-kftx0t13		PGX_AM_BS_MSK_IMPACT_2017-P_0011107_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9cz	pgxind-kftx7jhd	pgxcs-kftx0t7y		PGX_AM_BS_MSK_IMPACT_2017-P_0011125_T01_IM5	Spindle Cell Carcinoma of the Lung	NCIT:C45541	Lung Spindle Cell Carcinoma	pgx:icdom-80323	Spindle cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9f8	pgxind-kftx7jk7	pgxcs-kftx0twd		PGX_AM_BS_MSK_IMPACT_2017-P_0011183_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9h7	pgxind-kftx7jmq	pgxcs-kftx0ujm		PGX_AM_BS_MSK_IMPACT_2017-P_0011234_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9k1	pgxind-kftx7jq8	pgxcs-kftx0vfi		PGX_AM_BS_MSK_IMPACT_2017-P_0011303_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9ws	pgxind-kftx7k6e	pgxcs-kftx0zf8		PGX_AM_BS_MSK_IMPACT_2017-P_0012043_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvla5u	pgxind-kftx7khs	pgxcs-kftx128n		PGX_AM_BS_MSK_IMPACT_2017-P_0012287_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvla7c	pgxind-kftx7kjn	pgxcs-kftx12qp		PGX_AM_BS_MSK_IMPACT_2017-P_0012341_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlah8	pgxind-kftx7kw2	pgxcs-kftx15s3		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0000563_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlahr	pgxind-kftx7kwr	pgxcs-kftx15xv		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0001171_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlai5	pgxind-kftx7kx7	pgxcs-kftx161t		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0001867_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaiy	pgxind-kftx7ky8	pgxcs-kftx16ag		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0002731_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaki	pgxind-kftx7l05	pgxcs-kftx16sh		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0003970_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlakp	pgxind-kftx7l0d	pgxcs-kftx16uf		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0004279_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlakv	pgxind-kftx7l0l	pgxcs-kftx16wc		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0004472_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlala	pgxind-kftx7l14	pgxcs-kftx170n		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0004961_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlam3	pgxind-kftx7l24	pgxcs-kftx1799		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0006084_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlamh	pgxind-kftx7l2n	pgxcs-kftx17dj		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0006642_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlams	pgxind-kftx7l31	pgxcs-kftx17gy		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0007088_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlan5	pgxind-kftx7l3h	pgxcs-kftx17ml		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0007582_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaon	pgxind-kftx7l5d	pgxcs-kftx182f		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009469_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlapb	pgxind-kftx7l68	pgxcs-kftx189l		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0010213_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlapw	pgxind-kftx7l6y	pgxcs-kftx18ft		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0011180_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaq2	pgxind-kftx7l76	pgxcs-kftx18hq		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0011499_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaqf	pgxind-kftx7l7n	pgxcs-kftx18lh		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0012729_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaqm	pgxind-kftx7l7v	pgxcs-kftx18ne		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0012866_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaqn	pgxind-kftx7l7x	pgxcs-kftx18nw		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0012908_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaqs	pgxind-kftx7l83	pgxcs-kftx18pb		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0014172_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlar5	pgxind-kftx7l8j	pgxcs-kftx18v5		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0015296_T01_IM6	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlare	pgxind-kftx7l8w	pgxcs-kftx18y2		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0015785_T01_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlarg	pgxind-kftx7l8y	pgxcs-kftx18yk		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0015984_T01_IM6	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
